Cobiz Financial (COBZ) 10-Q 28 Oct 16 2016 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2016	Oct. 24, 2016
Document And Entity Information
Entity Registrant Name	COBIZ FINANCIAL INC
Entity Central Index Key	1,028,734
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2016
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,016
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Common Stock, Shares Outstanding		41,492,652

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Assets
Cash and due from banks	$ 58,532	$ 48,665
Interest-bearing deposits and federal funds sold	27,616	18,647
Total cash and cash equivalents	86,148	67,312
Investment securities available for sale (cost of $136,402 and $150,905, respectively)	140,283	153,685
Investment securities held to maturity (fair value of $308,998 and $345,576, respectively)	307,639	346,666
Other investments	7,160	12,461
Total investments	455,082	512,812
Loans - net of allowance for loan losses of $33,529 and $40,686, respectively	2,793,576	2,658,519
Intangible assets - net of amortization of $6,954 and $6,504, respectively	1,476	1,926
Bank-owned life insurance	53,307	49,373
Premises and equipment - net of depreciation of $41,111 and $39,504, respectively	9,293	6,122
Accrued interest receivable	10,994	10,362
Deferred income taxes, net	19,088	22,221
Other real estate owned - net of valuation allowance of $8,666	5,079	5,079
Other	18,455	18,041
TOTAL ASSETS	3,452,498	3,351,767
Liabilities
Noninterest-bearing demand	1,226,546	1,180,335
Interest-bearing demand	681,256	585,524
Money market	854,928	804,777
Savings	20,403	18,078
Certificates of deposit	154,060	152,998
Total deposits	2,937,193	2,741,712
Securities sold under agreements to repurchase	52,114	47,459
Other short-term borrowings	2,199	132,000
Accrued interest and other liabilities	33,899	25,863
Subordinated notes payable - net of unamortized discount and issuance costs of $910 and $969, respectively	59,090	59,031
Junior subordinated debentures	72,166	72,166
TOTAL LIABILITIES	3,156,661	3,078,231
Commitments and contingencies
Shareholders' Equity
Common stock, $.01 par value; 100,000,000 shares authorized; 41,465,452 and 41,122,119 issued and outstanding, respectively	410	406
Additional paid-in capital	196,263	192,768
Accumulated earnings	96,916	77,079
Accumulated other comprehensive income (AOCI), net of income tax of $1,379 and $2,013, respectively	2,248	3,283
TOTAL SHAREHOLDERS' EQUITY	295,837	273,536
TOTAL LIABILITIES AND EQUITY	$ 3,452,498	$ 3,351,767

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Investment securities available for sale, cost	$ 136,402	$ 150,905
Investment securities held to maturity, fair value	308,998	345,576
Allowance for loan losses	33,529	40,686
Intangible assets, amortization	6,954	6,504
Premises and equipment, depreciation	41,111	39,504
Other real estate owned assets, allowance	$ 8,666	$ 8,666
Preferred, par value	$ 0.01	$ 0.01
Preferred, shares authorized	2,000,000	2,000,000
Preferred, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	41,465,452	41,122,119
Common stock, shares outstanding	41,465,452	41,122,119
Accumulated other comprehensive income, tax	$ 1,379	$ 2,013
Subordinated notes payable
Discount and debt issuance costs	$ 910	$ 969

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
INTEREST INCOME:
Interest and fees on loans	$ 29,124	$ 26,758	$ 85,020	$ 79,959
Interest and dividends on investment securities:
Taxable securities	2,844	3,046	8,870	9,422
Nontaxable securities	179	238	538	408
Dividends on securities	111	103	473	309
Interest on federal funds sold and other	50	32	102	87
Total interest income	32,308	30,177	95,003	90,185
INTEREST EXPENSE:
Interest on deposits	996	916	2,840	2,722
Interest on short-term borrowings and securities sold under agreements to repurchase	60	46	470	135
Interest on subordinated debentures and notes payable	1,851	1,848	5,530	3,888
Total interest expense	2,907	2,810	8,840	6,745
NET INTEREST INCOME BEFORE PROVISION FOR LOAN LOSSES	29,401	27,367	86,163	83,440
Provision for loan losses	(1,168)	762	(2,450)	1,030
NET INTEREST INCOME AFTER PROVISION FOR LOAN LOSSES	30,569	26,605	88,613	82,410
NONINTEREST INCOME:
Service charges	1,553	1,490	4,508	4,438
Investment advisory income	1,416	1,478	4,296	4,444
Insurance income	3,120	3,023	9,282	9,110
Other income	3,197	1,433	6,700	4,690
Total noninterest income	9,286	7,424	24,786	22,682
NONINTEREST EXPENSE:
Salaries and employee benefits	17,480	16,623	53,093	51,718
Occupancy expenses, premises and equipment	4,025	3,371	11,032	9,778
Amortization of intangibles	150	150	450	450
FDIC and other assessments	369	459	1,297	1,350
Other real estate owned and loan workout costs	120	105	432	248
Net gain on securities, other assets and other real estate owned	(98)	(59)	(88)	(123)
Other expense	3,997	4,089	11,927	11,039
Total noninterest expense	26,043	24,738	78,143	74,460
INCOME BEFORE INCOME TAXES	13,812	9,291	35,256	30,632
Provision (benefit) for income taxes	3,543	2,337	9,090	8,892
NET INCOME FROM CONTINUING OPERATIONS	10,269	6,954	26,166	21,740
DISCONTINUED OPERATIONS
Loss from discontinued operations				(113)
Benefit for income taxes				(42)
Net loss from discontinued operations				(71)
NET INCOME	10,269	6,954	26,166	21,669
NET INCOME AVAILABLE TO COMMON SHAREHOLDERS	$ 10,269	$ 6,921	$ 26,166	$ 21,349
EARNINGS PER COMMON SHARE:
Basic	$ 0.25	$ 0.17	$ 0.63	$ 0.52
Diluted	$ 0.25	$ 0.17	$ 0.63	$ 0.52

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Net income	$ 10,269	$ 6,954	$ 26,166	$ 21,669
Cash flow hedges:
Net unrealized gain (loss)	507	(1,559)	(2,218)	(1,257)
Reclassification to operations	275	262	833	824
Total	782	(1,297)	(1,385)	(433)
Total other comprehensive income (loss) items	920	(2,300)	(1,669)	(1,243)
Cash flow hedges:
Net unrealized gain (loss)	193	(592)	(843)	(478)
Reclassification to operations	(105)	(99)	(317)	(313)
Total tax expense (benefit)	298	(493)	(526)	(165)
Total income tax provision (benefit)	350	(875)	(634)	(474)
Other comprehensive income (loss), net of tax	570	(1,425)	(1,035)	(769)
Comprehensive income	10,839	5,529	25,131	20,900
Available for sale securities
Other comprehensive income items:
Net unrealized gain (loss)	695	(402)	1,196	686
Reclassification to operations	(98)	15	(95)	(83)
Net unrealized holding gains transferred to held to maturity				(8,821)
Total	597	(387)	1,101	(8,218)
Income tax provision:
Net unrealized gain (loss)	263	(152)	454	261
Reclassification to operations	(37)	4	(36)	(33)
Net unrealized holding gains transferred to held to maturity				(3,352)
Total tax expense (benefit)	226	(148)	418	(3,124)
Held to maturity securities
Other comprehensive income items:
Reclassification to operations	(459)	(616)	(1,385)	(1,413)
Net unrealized holding gains transferred to held to maturity				8,821
Total	(459)	(616)	(1,385)	7,408
Income tax provision:
Reclassification to operations	(174)	(234)	(526)	(537)
Net unrealized holding gains transferred to held to maturity				3,352
Total tax expense (benefit)	$ (174)	$ (234)	$ (526)	$ 2,815

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 26,166	$ 21,669
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization and accretion	3,319	2,880
Provision for loan losses	(2,450)	1,030
Stock-based compensation	2,492	2,611
Deferred income taxes	3,599	1,018
Excess tax benefit from stock-based compensation		(610)
Bank-owned life insurance	(1,000)	(980)
Net gain on securities, other assets and other real estate owned	(88)	(123)
Other operating activities, net	122	(555)
Changes in operating assets and liabilities:
Other assets	81	(1,549)
Other liabilities	2,872	(898)
Net cash provided by operating activities	35,113	24,493
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of other investments	(11,489)	(10,958)
Proceeds from other investments	17,487	12,407
Purchases of investment securities available for sale	(1,970)	(39,774)
Purchases of investment securities held to maturity	(12,651)	(74,813)
Maturity, call and principal payments on investment securities available for sale	16,251	36,918
Maturity, call and principal payment on investment securities held to maturity	48,253	44,831
Acquisition of client relationships		(75)
Purchase of bank-owned life insurance	(3,195)
Net proceeds from sale of loans, OREO and repossessed assets	60	2,073
Loan originations and repayments, net	(128,944)	(213,474)
Purchase of premises and equipment	(5,355)	(962)
Other investing activities, net	272
Net cash used in investing activities	(81,281)	(243,827)
CASH FLOWS FROM FINANCING ACTIVITIES:
Net increase in demand, money market and savings accounts	194,419	269,982
Net increase (decrease) in certificates of deposits	1,062	(54,860)
Net decrease in short-term borrowings	(129,801)	(2,469)
Net increase (decrease) in securities sold under agreements to repurchase	4,655	12,206
Net proceeds from issuance of subordinated notes payable		58,992
Proceeds from issuance of common stock, net	1,342	1,233
Taxes paid in net settlement of restricted stock	(890)	(1,183)
Redemption of preferred stock		(57,366)
Dividends paid on common stock	(5,783)	(5,107)
Dividends paid on preferred stock		(320)
Excess tax benefit from stock-based compensation		610
Net cash provided by financing activities	65,004	221,718
NET INCREASE IN CASH AND CASH EQUIVALENTS	18,836	2,384
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	67,312	91,565
CASH AND CASH EQUIVALENTS, END OF PERIOD	$ 86,148	$ 93,949

Nature of Operations and Signif

Nature of Operations and Significant Accounting Policies	9 Months Ended
	Sep. 30, 2016
Nature of Operations and Significant Accounting Policies
Nature Of Operations and Significant Accounting Policies	1. Nature of Operations and Significant Accounting Policies The accompanying unaudited Condensed Consolidated Financial Statements of CoBiz Financial Inc. (Parent or Holding Company), and its wholly-owned subsidiaries: CoBiz Bank (Bank); CoBiz Insurance, Inc.; and CoBiz IM, Inc. (CoBiz IM); all collectively referred to as the “Company”, “CoBiz”, “we”, “us”, or “our” conform to Generally Accepted Accounting Principles (GAAP) in the United States of America for interim financial information and prevailing practices within the banking industry. The operations of the Company are comprised predominantly of the Bank, which operates in its Colorado market areas under the name Colorado Business Bank (CBB) and in its Arizona market areas under the name Arizona Business Bank (ABB). Organization — The Bank is a commercial banking institution with nine locations in the Denver metropolitan area; one in Boulder; one near Vail; one in Colorado Springs; one in Fort Collins; and four in the Phoenix metropolitan area. As a state chartered bank, deposits are insured by the Bank Insurance Fund of the Federal Deposit Insurance Corporation (FDIC) and the Bank is subject to supervision, regulation and examination by the Federal Reserve, Colorado Division of Banking and the FDIC. Pursuant to such regulations, the Bank is subject to special restrictions, supervisory requirements and potential enforcement actions. CoBiz Insurance, Inc. provides commercial and personal property and casualty (P&C) insurance brokerage, risk management consulting services to small and medium-sized businesses and individuals and provides employee benefits consulting, insurance brokerage and related administrative support to employers. CoBiz IM provides wealth planning and investment management to institutions and individuals through its SEC-registered investment advisor subsidiary, CoBiz Wealth, LLC. Use of Estimates – In preparing its financial statements, the Company is required to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. The following is a summary of certain of the Company’s significant accounting and reporting policies. Basis of Presentation —These Condensed Consolidated Financial Statements and notes thereto should be read in conjunction with, and are qualified in their entirety by, the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the U.S. Securities and Exchange Commission (SEC). The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting only of normally recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2016, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2016. The Condensed Consolidated Financial Statements include entities in which the Parent has a controlling financial interest. These entities include: the Bank; CoBiz Insurance, Inc.; and CoBiz IM. Intercompany balances and transactions are eliminated in consolidation. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity (VIE). The voting interest model is used when the equity investment is sufficient to absorb the expected losses and the equity investment has all of the characteristics of a controlling financial interest. Under the voting interest model, the party with the controlling voting interest consolidates the legal entity. The VIE model is used when any of the following conditions exist: the equity investment at risk is not sufficient to finance the entity’s activities without additional subordinated financial support; the holders of the equity investment do not have a controlling voting interest; or the holders of the equity investment are not obligated to absorb the expected losses or residual returns of the legal entity. An enterprise is considered to have a controlling financial interest of a VIE if it has both the power to direct the activities that most significantly impact economic performance and the obligation to absorb losses, or receive benefits, that are significant to the VIE. An enterprise that has a controlling financial interest is considered the primary beneficiary and must consolidate the VIE. The Company was not the primary beneficiary of a VIE at September 30, 2016 or December 31, 2015. Certain reclassifications have been made to prior years’ Condensed Consolidated Financial Statements and related notes to conform to the current year presentation. Cash and Cash Equivalents — The Company considers all liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include amounts that the Company is required to maintain at the Federal Reserve Bank of Kansas City to meet certain regulatory reserve balance requirements. The following table shows supplemental disclosures of certain cash and noncash items: Nine months ended September 30, (in thousands) 2016 2015 Cash paid during the period for: Interest $ $ Income taxes Other noncash activities: Available for sale securities transferred to held to maturity $ - $ Loans transferred to held for sale Investments — The Company classifies its investment securities as held to maturity, available for sale or trading, according to management’s intent. Investment security transactions are recorded on a trade date basis. At September 30, 2016 and December 31, 2015, the Company had no trading securities. Available for sale securities consist of bonds, notes and debentures (including corporate debt and trust preferred securities (TPS)) not classified as held to maturity securities and are reported at fair value as determined by quoted market prices. Unrealized holding gains and losses, net of tax, are reported as a net amount in AOCI until realized. Investment securities held to maturity consist of residential mortgage-backed securities (MBS), bonds, notes and debentures for which the Company has the intent and ability to hold to maturity and are reported at cost, adjusted for amortization or accretion of premiums and discounts. Premiums and discounts, adjusted for prepayments as applicable, are recognized in interest income. Other than temporary declines in the fair value of individual investment securities held to maturity and available for sale are charged against earnings. Gains and losses on disposal of investment securities are determined using the specific-identification method. Other-than-temporary-impairment (OTTI) on debt securities is separated between the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income (OCI). Bank Stocks — Federal Home Loan Bank of Topeka (FHLB), Federal Reserve Bank and other correspondent bank stocks are accounted for under the cost method. Loans Held for Investment — Loans that the Company has the intent and ability to hold for the foreseeable future or until maturity or pay-off are reported at their outstanding principal balances adjusted for any charge-offs, the allowance for loan losses, deferred fees and costs on originated loans, and unamortized premiums or discounts on purchased loans. Interest is accrued and credited to income daily based on the principal balance outstanding. The accrual of interest income is generally discontinued when a loan becomes 90 days past due as to principal and interest. When a loan is designated as nonaccrual, the current period’s accrued interest receivable is charged against current earnings while any portions relating to prior periods are charged against the allowance for loan losses. Interest payments received on nonaccrual loans are generally applied to the principal balance of the loan. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured and there has been demonstrated performance in accordance with contractual terms. The Company may elect to continue the accrual of interest when the loan is in the process of collection and the realizable value of collateral is sufficient to cover the principal balance and accrued interest. Loans Held for Sale — Loans held for sale include loans the Company has demonstrated the ability and intent to sell. Loans held for sale are primarily nonperforming loans. Loans held for sale are carried at the lower of cost or fair value and are evaluated on a loan-by-loan basis. Impaired Loans — Impaired loans, with the exception of groups of smaller-balance homogenous loans that are collectively evaluated for impairment, are defined as loans for which, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays of less than 90 days and monthly payment shortfalls of less than 10% of the contractual payment on a consumer loan generally are not classified as impaired if the Company ultimately expects to recover its full investment. The Company determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Loans that are deemed to be impaired are evaluated in accordance with Accounting Standards Codification (ASC) Topic 310-10-35, Receivables – Subsequent Measurement (ASC 310) and ASC Topic 450-20, Loss Contingencies (ASC 450). Included in impaired loans are troubled debt restructurings. A troubled debt restructuring is a formal restructure of a loan where the Company, for economic or legal reasons related to the borrower’s financial difficulties, grants a concession to the borrower. The concessions may be granted in various forms, including but not limited to reduction in the stated interest rate, reduction in the loan balance or accrued interest, or extension of the maturity date. Troubled debt restructurings are evaluated in accordance with ASC Topic 310-40, Troubled Debt Restructurings by Creditors. Interest payments on impaired loans are typically applied to principal unless collectability of principal is reasonably assured. Loans that have been modified in a formal restructuring are typically returned to accrual status when there has been a sustained period of performance (generally six months) under the modified terms, the borrower has shown the ability and willingness to repay and the Company expects to collect all amounts due under the modified terms. Loan Origination Fees and Costs — Loan fees and certain costs of originating loans are deferred and the net amount is amortized over the contractual life of the related loans in accordance with ASC Topic 310-20, Nonrefundable Fees and Other Costs. Allowance for Loan Losses — The allowance for loan losses (ALL) is established as losses are estimated to have occurred through a provision for loan losses charged against earnings. Loan losses are charged against the allowance when management believes the uncollectability of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the allowance. The ALL is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral, and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as new information becomes available. Allowance for Credit Losses — The allowance for credit losses is established as losses are estimated to have occurred through a provision for credit losses charged to earnings. The allowance for credit losses represents management’s recognition of a separate reserve for off-balance sheet loan commitments and letters of credit. While the allowance for loan losses is recorded as a contra-asset to the loan portfolio on the Condensed Consolidated Balance Sheets, the allowance for credit losses is recorded under the caption “Accrued interest and other liabilities”. Although the allowances are presented separately on the balance sheets, any losses incurred from credit losses would be reported as a charge-off in the allowance for loan losses, as any loss would be recorded after the off-balance sheet commitment had been funded. Bank-Owned Life Insurance (BOLI) – The Bank invested in BOLI policies to fund certain future employee benefit costs. The policies are recorded at net realizable value. Changes in the amount that could be realized and amounts realized from policy claims are recorded in the Condensed Consolidated Statements of Income as “Other income”. Derivative Instruments — Derivative financial instruments are accounted for at fair value. The Company utilizes interest rate swaps to hedge a portion of its exposure to interest rate changes. These instruments are accounted for as cash flow hedges, as defined by ASC Topic 815, Derivatives and Hedging (ASC 815). The Company also uses interest rate swaps to hedge against adverse changes in fair value on fixed-rate loans. These instruments are accounted for as fair value hedges in accordance with ASC 815. The net cash flows from these hedges are classified in operating activities within the Condensed Consolidated Statements of Cash Flows with the hedged items. The Company also has a derivative program that offers interest rate caps, floors, swaps and collars to customers of the Bank. The fair value amounts recognized for derivative instruments and the fair value amounts recognized for the right to reclaim or obligation to return cash collateral are not offset when represented under a master netting arrangement. The Company also uses foreign currency forward contracts (FX forwards) giving it the right to sell underlying currencies at specified future dates and predetermined prices in order to mitigate foreign exchange risk associated with long positions. FX forwards are carried at fair value with changes in value recognized in current earnings as the contracts are not designated as hedging instruments. Fair Value Measurements — The Company measures financial assets, financial liabilities, nonfinancial assets and nonfinancial liabilities pursuant to ASC Topic 820, Fair Value Measurement (ASC 820). ASC 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. Loss From Discontinued Operations, Net of Income Taxes — During the first quarter of 2015, the Company ceased the operations of its investment banking subsidiary due to increasing regulatory compliance costs and to focus on activities that provide recurring revenue. Investment banking revenue was transactional and highly dependent on deal volume which could vary significantly from period to period.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2016
Recent Accounting Pronouncements
Recent Accounting Pronouncements	2. Recent Accounting Pronouncements In February 2016, the Financial Accounting Standard Board (FASB) issued Accounting Standard Update (ASU) 2016-02, Leases (Topic 842) (ASU 2016-02). ASU 2016-02 is intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. For public business entities, this ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018. The Company is currently evaluating the effects of ASU 2016-02 on its financial statements and disclosures. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting (ASU 2016-09). ASU 2016-09 includes provisions intended to simplify various aspects related to accounting for and presentation of share-based payments in the financial statements. The areas for simplification include income tax consequences, forfeitures, classification of awards as either equity or liabilities and classification on the statement of cash flows. This ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2016, and early adoption is permitted for financial statements that have not been previously issued. The Company early adopted the provisions of ASU 2016-09 during the quarter ended March 31, 2016. The cumulative effect adjustment from the modified retrospective transition of the income tax consequences, forfeitures and the classification of awards did not have a material effect on the Company’s financial statements or disclosures. Changes to the statement of cash flows have been applied prospectively beginning in the first quarter of 2016. See Note 9 - Employee Benefit and Stock Compensation Plans. In May 2014, the FASB issued ASU No. 2014-9 (ASU 2014-09), Revenue from Contracts with Customers. The core principle of ASU 2014-09 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also specifies the accounting for some costs to obtain or fulfill a contract with a customer, as well as enhanced disclosure requirements. In August 2015, the FASB issued ASU 2015-14 which deferred the effective date of ASU 2014-09 to fiscal years, and interim reporting periods within those fiscal years, beginning after December 15, 2017. In March 2016, the FASB issued ASU 2016-08 which clarified the revenue recognition implementation guidance on principal versus agent considerations and is effective during the same period as ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation and is effective during the same period as ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU 2016-12 is effective during the same period as ASU 2014-09. The Company is currently evaluating the effects of ASU 2014-09, ASU 2016-08, ASU 2016-10 and ASU 2016-12 on its financial statements and disclosures, if any. Preliminarily, the Company expects these ASUs to have more of an impact on the Fee-Based Lines segment than Commercial Banking segment, which generates the majority of the Company’s revenue. In June 2016, the FASB issued ASU 2016-13 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2019, and early adoption is permitted for fiscal years, including interim periods, beginning after December 15, 2018. ASU 2016-13 will be applied through a cumulative effect adjustment to retained earnings (modified-retrospective approach), except for debt securities for which an other-than-temporary impairment had been recognized before the effective date. A prospective transition approach is required for these debt securities. While the Company is currently evaluating the effects of ASU 2016-13 on its financial statements and disclosures, the Company does expect ASU 2016-13 to add complexity and costs to its current credit loss evaluation process. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15), regarding how certain cash receipts and cash payments are presented and classified in the statements of cash flows. ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice. The amendments of ASU 2016-13 are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company is evaluating the effects ASU 2016-15 will have on its financial statements and disclosures and does not expect these effects to be material.

Earnings per Common Share and D

Earnings per Common Share and Dividends Declared per Common Share	9 Months Ended
	Sep. 30, 2016
Earnings per Common Share and Dividends Declared per Common Share
Earnings per Common Share and Dividends Declared per Common Share	3. Earnings per Common Share and Dividends Declared per Common Share Earnings per common share is calculated based on the two-class method prescribed in ASC 260, Earnings per Share . The two-class method is an allocation of undistributed earnings to common stock and securities that participate in dividends with common stock. The Company’s restricted stock awards are considered participating securities since the recipients receive non-forfeitable dividends on unvested awards. The impact of participating securities is included in basic earnings per common share for the three and nine months ended September 30, 2016 and 2015. Net loss per common share from discontinued operations was not material in the presented periods and has been excluded from the following table. Income allocated to common shares and weighted average shares outstanding used in the calculation of basic and diluted earnings per common share are as follows: Three months ended Nine months ended September 30, September 30, (in thousands, except share and per share amounts) 2016 2015 2016 2015 Net income from continuing operations $ $ $ $ Net loss from discontinued operations - - - Net income Preferred stock dividends - - Net income available to common shareholders Dividends and undistributed earnings allocated to participating securities Earnings allocated to common shares (1) $ $ $ $ Weighted average common shares - issued Average unvested restricted share awards Weighted average common shares outstanding - basic Effect of dilutive stock options and awards outstanding Weighted average common shares outstanding - diluted Weighted average antidilutive securities outstanding (2) Basic earnings per common share $ $ $ $ Diluted earnings per common share $ $ $ $ Dividends declared per share $ $ $ $ (1) Earnings allocated to common shareholders for basic earnings per common share under the two-class method may differ from earnings allocated for diluted earnings per common share when use of the treasury method results in greater dilution than the two-class method. (2) Antidilutive shares excluded from the diluted earnings per common share computation.

Investments

Investments	9 Months Ended
	Sep. 30, 2016
Investments
Investments	4. Investments The amortized cost and estimated fair values of investment securities are summarized as follows: At September 30, 2016 At December 31, 2015 Gross Gross Gross Gross Amortized unrealized unrealized Fair Amortized unrealized unrealized Fair (in thousands) cost gains losses value cost gains losses value Available for sale securities (AFS): Trust preferred securities $ $ $ $ $ $ $ $ Corporate debt securities Municipal securities - Total AFS $ $ $ $ $ $ $ $ Held to maturity securities (HTM): Mortgage-backed securities $ $ $ $ $ $ $ $ Trust preferred securities Municipal securities Total HTM $ $ $ $ $ $ $ $ The amortized cost and estimated fair value of investments in debt securities at September 30, 2016, by contractual maturity are shown below. Expected maturities can differ from contractual maturities because borrowers may have the right to call or prepay obligations with or without penalties. Available for sale Held to maturity Amortized Fair Amortized Fair (in thousands) cost value cost value Due in one year or less $ $ $ - $ - Due after one year through five years Due after five years through ten years Due after ten years Mortgage-backed securities - - $ $ $ $ The Company uses investment securities to collateralize public deposits. Investment securities with an approximate fair value of $145.0 million and $157.3 million were pledged to secure public deposits of $116.2 million and $113.6 million at September 30, 2016 and December 31, 2015, respectively. Changes in interest rates and market liquidity may cause adverse fluctuations in the market price of securities resulting in temporary unrealized losses. In reviewing the realizable value of its securities in a loss position, the Company considered the following factors: (1) the length of time and extent to which the market had been less than cost; (2) the financial condition and near-term prospects of the issuer; (3) investment downgrades by rating agencies; and (4) whether it is more likely than not that the Company will have to sell the security before a recovery in value. When it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the security, and the fair value of the investment security is less than its amortized cost, an other-than-temporary impairment is recognized in earnings. For debt securities that are considered other-than temporarily impaired and that the Company does not intend to sell and will not be required to sell prior to recovery of the amortized cost basis, an OTTI is recognized. OTTI is separated into the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income. The Company did not have any credit impaired securities at September 30, 2016 and December 31, 2015. There were 115 and 168 securities in the tables below at September 30, 2016 and December 31, 2015, respectively, in an unrealized loss position. September 30, 2016 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ $ $ $ $ $ Corporate debt securities - - Total AFS $ $ $ $ $ $ HTM Mortgage-backed securities $ $ $ $ $ $ Trust preferred securities Municipal securities - - Total HTM $ $ $ $ $ $ December 31, 2015 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ $ $ $ $ $ Corporate debt securities - - Municipal securities - - Total AFS $ $ $ $ $ $ HTM Mortgage-backed securities $ $ $ - $ - $ $ Trust preferred securities - - Municipal securities - - Total HTM $ $ $ $ $ $ Other investments at September 30, 2016 and December 31, 2015, consisted of the following: September 30, December 31, (in thousands) 2016 2015 Bank stocks — at cost $ $ Investment in statutory trusts — equity method Total $ $ Bank stocks consist primarily of stock in the FHLB, which is part of the Federal Home Loan Bank System (FHLB System). The purpose of the FHLB investment relates to maintenance of a borrowing base with the FHLB. FHLB stock holdings are largely dependent upon the Company’s liquidity position. To the extent the need for wholesale funding increases or decreases, the Company may purchase additional or sell excess FHLB stock, respectively. The Company evaluates impairment in this investment based on the ultimate recoverability of the par value. At September 30, 2016, the Company did not consider the investment to be other-than-temporarily impaired.

Loans

Loans	9 Months Ended
	Sep. 30, 2016
Loans
Loans	5. Loans The following disclosure reports the Company’s loan portfolio segments and classes. Segments are groupings of similar loans at a level which the Company has adopted systematic methods of documentation for determining its allowance for loan and credit losses. Classes are a disaggregation of the portfolio segments. The Company’s loan portfolio segments are: · Commercial loans – Commercial loans consist of loans to small and medium-sized businesses in a wide variety of industries. The Bank’s areas of emphasis in commercial lending include, but are not limited to, loans to wholesalers, manufacturers, municipalities, construction and business services companies. Commercial loans are generally collateralized by inventory, accounts receivable, equipment, real estate and other commercial assets, and may be supported by other credit enhancements such as personal guarantees. Risk arises primarily due to a difference between expected and actual cash flows of the borrowers. However, the recoverability of the Company’s investment in these loans is also dependent on other factors primarily dictated by the type of collateral securing these loans. The fair value of the collateral securing these loans may fluctuate as market conditions change. In the case of loans secured by accounts receivable, the recovery of the Company’s investment is dependent upon the borrowers’ ability to collect amounts due from its customers. · Real estate - mortgage loans – Real estate mortgage loans include various types of loans for which the Company holds real property as collateral. Commercial real estate lending activity is typically restricted to owner-occupied properties or to investor properties that are owned by customers with a current banking relationship. The primary risks of real estate mortgage loans include the borrower’s inability to pay, material decreases in the value of the real estate that is being held as collateral and significant increases in interest rates, which may make the real estate mortgage loan unprofitable. Real estate loans may be more adversely affected by conditions in the real estate markets or in the general economy. · Construction and land – The Company originates loans to finance construction projects including one- to four-family residences, multifamily residences, commercial office, senior housing, and industrial projects. Residential construction loans are due upon the sale of the completed project and are generally collateralized by first liens on the real estate and have floating interest rates. Construction loans are considered to have higher risks due to construction completion and timing risk, and the ultimate repayment being sensitive to interest rate changes, governmental regulation of real property and the availability of long-term financing. Additionally, economic conditions may impact the Company’s ability to recover its investment in construction loans. Adverse economic conditions may negatively impact the real estate market which could affect the borrowers’ ability to complete and sell the project. Additionally, the fair value of the underlying collateral may fluctuate as market conditions change. The Company also originates loans for the acquisition and future development of land for residential building projects, as well as finished lots prepared to enter the construction phase. The primary risks include the borrower’s inability to pay and the inability of the Company to recover its investment due to a decline in the fair value of the underlying collateral. · Consumer loans – The Company provides a broad range of consumer loans to customers, including personal lines of credit, home equity loans, mortgage loans and automobile loans. Repayment of these loans is dependent on the borrowers’ ability to pay and the fair value of the underlying collateral. · Other loans – Other loans include lending products, such as taxable and tax exempt leasing, not defined as commercial, real estate, acquisition and development, construction, or consumer loans. The loan portfolio segments at September 30, 2016 and December 31, 2015 were as follows: (in thousands) At September 30, 2016 At December 31, 2015 Commercial $ $ Real estate - mortgage Construction & land Consumer Other Loans held for investment Allowance for loan losses Unearned net loan fees Total net loans $ $ The Company uses qualifying loans as collateral for advances and a line of credit from the FHLB. The FHLB line of credit did not have an outstanding balance at September 30, 2016. The Company pledged loans of $838.0 million with a lending value of $581.8 million as collateral for the FHLB line of credit. The Company maintains a loan review program independent of the lending function that is designed to reduce and control risk in lending. It includes the continuous monitoring of lending activities with respect to underwriting and processing new loans, preventing insider abuse and timely follow-up and corrective action for loans showing signs of deterioration in quality. The Company also has a systematic process to evaluate individual loans and pools of loans within our loan portfolio. The Company maintains a loan grading system whereby each loan is assigned a grade between 1 and 8, with 1 representing the highest quality credit, 7 representing a nonaccrual loan where collection or liquidation in full is highly questionable and improbable, and 8 representing a loss that has been or will be charged-off. Grades are assigned based upon the degree of risk associated with repayment of a loan in the normal course of business pursuant to the original terms. Loans that are graded 5 or better are categorized as non-classified credits while loans graded 6 and worse are categorized as classified credits. Loan grade changes are evaluated on a monthly basis. Loans above a certain dollar amount that are adversely graded are reported to the Special Assets Group Manager and the Chief Credit Officer along with current financial information, a collateral analysis and an action plan. The loan portfolio showing total non-classified and classified balances by loan class at September 30, 2016 and December 31, 2015 is summarized below: At September 30, 2016 (in thousands) Non-classified Classified Total Commercial Manufacturing $ $ $ Finance and insurance Healthcare Real estate services Construction Public administration Other Real estate - mortgage Residential & commercial owner-occupied Residential & commercial investor Construction & land - Consumer Other Total loans held for investment $ $ $ Unearned net loan fees Net loans held for investment $ At December 31, 2015 (in thousands) Non-classified Classified Total Commercial Manufacturing $ $ $ Finance and insurance Healthcare Real estate services Construction Public administration Other Real estate - mortgage Residential & commercial owner-occupied Residential & commercial investor Other - Construction & land Consumer Other Total loans held for investment $ $ $ Unearned net loan fees Net loans held for investment $ Transactions in the allowance for loan losses by segment for the three and nine months ended September 30, 2016 and 2015 are summarized below: Three months ended September 30, Nine months ended September 30, (in thousands) 2016 2015 2016 2015 Allowance for loan losses, beginning of period Commercial $ $ $ $ Real estate - mortgage Construction & land Consumer Other Unallocated Total Provision Commercial $ $ $ $ Real estate - mortgage Construction & land Consumer Other Unallocated Total Charge-offs Commercial $ $ $ $ Real estate - mortgage - - Construction & land - - - Consumer - Other Total Recoveries Commercial $ $ $ $ Real estate - mortgage Construction & land Consumer Other - - - Total Allowance for loan losses, end of period Commercial $ $ $ $ Real estate - mortgage Construction & land Consumer Other Unallocated Total $ $ $ $ The Company estimates the ALL in accordance with ASC 310 for purposes of evaluating loan impairment on a loan-by-loan basis and ASC 450 for purposes of collectively evaluating loan impairment by grouping loans with common risk characteristics (i.e. risk classification, past-due status, type of loan, and collateral). The ALL is comprised of the following components: · Specific Reserves – The Company continuously evaluates its reserve for loan losses to maintain an adequate level to absorb loan losses incurred in the loan portfolio. Reserves on loans identified as impaired, including troubled debt restructurings, are based on discounted expected cash flows using the loan’s initial effective interest rate, the observable market value of the loan or the fair value of the collateral for certain collateral-dependent loans. The fair value of the collateral is determined in accordance with ASC 820. Loans are considered to be impaired in accordance with the provisions of ASC 310 when it is probable that all amounts due in accordance with the contractual terms will not be collected. Factors contributing to the determination of specific reserves include the financial condition of the borrower, changes in the value of pledged collateral and general economic conditions. Troubled debt restructurings meet the definition of an impaired loan under ASC 310 and therefore, troubled debt restructurings are subject to impairment evaluation on a loan-by-loan basis. For collateral dependent loans that have been specifically identified as impaired, the Company measures fair value based on third-party appraisals, adjusted for estimated costs to sell the property. Upon impairment, the Company will obtain a new appraisal if one had not been previously obtained in the last 12 months. For credits over $2.0 million, the Company engages an additional third-party appraiser to review the appraisal. For credits under $2.0 million, the Company’s internal appraisal department reviews the appraisal. All appraisals are reviewed for reasonableness based on recent sales transactions that may have occurred subsequent to or at the time of the appraisal. Based on this analysis, the appraised value may be adjusted downward if there is evidence that the appraised value may not be indicative of fair value. Each appraisal is updated on an annual basis, either through a new appraisal or through the Company’s comprehensive internal review process. Values are reviewed and monitored internally and fair value is re-assessed at least quarterly or more frequently when events or circumstances occur that indicate a change in fair value. It has been the Company’s experience that appraisals quickly become outdated due to the volatile real estate environment. As such, fair value based on property appraisals may be adjusted to reflect estimated declines in the fair value of properties since the time the last appraisal was performed. · General Reserves – General reserves are considered part of the allocated portion of the ALL. The Company uses a comprehensive loan grading process for its loan portfolios. Based on this process, a loss factor is assigned to each pool of graded loans. A combination of loss experience and external loss data is used in determining the appropriate loss factor. This estimate represents the probable incurred losses within the portfolio. In evaluating the adequacy of the ALL, management considers historical losses (Migration), as well as other factors including changes in: · Lending policies and procedures · National and local economic and business conditions and developments · Nature and volume of portfolio · Trends of the volume and severity of past-due and classified loans · Trends in the volume of nonaccrual loans, troubled debt restructurings, and other loan modifications · Credit concentrations Troubled debt restructurings have a direct impact on the ALL to the extent a loss has been recognized in relation to the loan modified. This is consistent with the Company’s consideration of Migration in determining general reserves. The aforementioned factors enable management to recognize environmental conditions contributing to incurred losses in the portfolio, which have not yet manifested in Migration. Management believes Migration history captures probable incurred losses within the portfolio. In addition to the allocated reserve for graded loans, a portion of the ALL is determined by segmenting the portfolio into product groupings with similar risk characteristics. Part of the segmentation involves assigning increased reserve factors to those lending activities deemed higher-risk, such as leverage-financings, unsecured loans, certain loans lacking personal guarantees, and multifamily loans. · Unallocated Reserves – The unallocated reserve, which is judgmentally determined, is maintained to recognize the imprecision in estimating and measuring loss when evaluating reserves for individual loans or pools of loans. The unallocated reserve consists of a missed grade component that is intended to capture the inherent risk that certain loans may be assigned an incorrect loan grade. In assessing the reasonableness of management’s assumptions, consideration is given to select peer ratios, industry standards and directional consistency of the ALL. Ratio analysis highlights divergent trends in the relationship of the ALL to nonaccrual loans, to total loans and to historical charge-offs. Although these comparisons can be helpful as a supplement to assess reasonableness of management assumptions, they are not, by themselves, sufficient basis for determining the adequacy of the ALL. While management utilizes its best judgment and information available, the ultimate adequacy of the allowance is dependent upon a variety of factors beyond the Company’s control, including the performance of the loan portfolio, the economy, changes in interest rates and the view of the regulatory authorities toward loan classifications. The following table summarizes loans held for investment and the allowance for loan and credit losses on the basis of the impairment method: At September 30, 2016 At December 31, 2015 Individually evaluated for impairment Collectively evaluated for impairment Individually evaluated for impairment Collectively evaluated for impairment (in thousands) Loans Allowance Loans Allowance Loans Allowance Loans Allowance Commercial $ $ $ $ $ $ $ $ Real estate - mortgage Construction & land Consumer Other - - - - Unallocated - - - - - - Total $ $ $ $ $ $ $ $ Information on impaired loans at September 30, 2016 and December 31, 2015 is reported in the following tables: At September 30, 2016 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans (1) allowance allowance allowance Commercial Manufacturing $ $ $ $ $ Finance and insurance - Healthcare - Real estate services - Construction Other Real estate - mortgage Residential & commercial owner-occupied Residential & commercial investor - Construction & land - Consumer Total $ $ $ $ $ At December 31, 2015 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans (1) allowance allowance allowance Commercial Manufacturing $ $ $ $ - $ Finance and insurance - Healthcare - Real estate services - Construction - Other Real estate - mortgage Residential & commercial owner-occupied Residential & commercial investor - Construction & land Consumer Total $ $ $ $ $ (1) Recorded investment in impaired loans in this table may not agree to loans individually evaluated for impairment disclosed in the previous table due to certain loans being excluded pursuant to ASC 310-40-50-2. Interest income recognized on impaired loans presented in the table below primarily represents interest earned on troubled debt restructurings that meet the definition of an impaired loan pursuant to ASU 310-10-35-16 and are subject to disclosure requirement under ASU 310-10-50-15. Impaired loans Three months ended September 30, Nine months ended September 30, 2016 2015 2016 2015 (in thousands) Average recorded Interest income Average recorded Interest income Average recorded Interest income Average recorded Interest income Commercial Manufacturing $ $ $ $ $ $ $ $ Finance and insurance - - Healthcare - - - - Real estate services Construction Other Real estate - mortgage Residential & commercial owner-occupied - Residential & commercial investor Construction & land Consumer Other - - - - - - Total $ $ $ $ $ $ $ $ The table below summarizes transactions related to troubled debt restructurings during the nine months ended September 30, 2016. (in thousands) Performing Nonperforming Total Beginning balance at December 31, 2015 $ $ $ New restructurings Change in accrual status - Net paydowns Charge-offs - Ending balance at September 30, 2016 $ $ $ At September 30, 2016 and December 31, 2015, there were $1.5 million and $1.7 million in outstanding commitments on restructured loans, respectively. The below table provides information regarding troubled debt restructurings that occurred during the three and nine months ended September 30, 2016 and 2015. Pre-modification outstanding recorded investment reflects the Company’s recorded investment immediately before the modification. Post-modification outstanding recorded investment represents the Company’s recorded investment at the end of the reporting period. The table below does not include loans restructured and paid-off during the periods presented. Three months ended September 30, 2016 Three months ended September 30, 2015 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing - $ - $ - $ $ Construction Other Total $ $ $ $ Nine months ended September 30, 2016 Nine months ended September 30, 2015 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing $ $ $ $ Finance and insurance - - - Healthcare - - - Construction Other Real estate - mortgage Residential and commercial owner-occupied - - - Consumer Total $ $ $ $ Troubled debt restructurings during the three and nine months ended September 30, 2016 and 2015 resulted primarily from the extension of repayment terms and interest rate concessions. The Company had no charge-offs in conjunction with loans restructured during the three and nine months ended September 30, 2016 and 2015. The following table presents troubled loans restructured within the past 12 months that had a payment default during the nine months ended September 30, 2016 and 2015. Nine months ended September 30, 2016 2015 Troubled debt restructurings that subsequently defaulted Number of contracts Recorded investment Number of contracts Recorded investment Commercial Other $ - $ - Total $ - $ - The allowance for loan losses on troubled debt restructurings included in the table above was $1.1 million at September 30, 2016. The Company’s nonaccrual loans by class at September 30, 2016 and December 31, 2015 are reported in the following table: (in thousands) At September 30, 2016 At December 31, 2015 Commercial Manufacturing $ $ Finance and insurance Real estate services - Construction Other Total commercial Residential & commercial owner-occupied Construction & land - Consumer Total nonaccrual loans $ $ The tables below summarize the aging of the Company’s loan portfolio at September 30, 2016 and December 31, 2015. The Company did not have any loans 90 days or more past due and accruing at September 30, 2016. At September 30, 2016 30 - 59 60 - 89 Days Days 90+ Days Total (in thousands) past due past due past due past due Current Total loans Commercial Manufacturing $ - $ - $ $ $ $ Finance and insurance - Healthcare - - Real estate services - - Construction - - - - Public administration - - - - Other - Real estate - mortgage Residential & commercial owner-occupied - - Residential & commercial investor - - - Construction & land - - - - Consumer - - Other - - - - Total loans held for investment $ $ $ $ $ $ Unearned net loan fees Net loans held for investment $ At December 31, 2015 Recorded investment in loans 30 - 59 60 - 89 90 days or more Days Days 90+ Days Total past due and (in thousands) past due past due past due past due Current Total loans accruing Commercial Manufacturing $ $ - $ - $ $ $ $ - Finance and insurance - - - - - Healthcare - - - Real estate services - - - Construction - - - - - Public administration - - - - - Other - - Real estate - mortgage Residential & commercial owner-occupied - - - Residential & commercial investor - - - - - Other - - - - - - - - Construction & land - - - Consumer - Other - - - - - Total loans held for investment $ $ $ $ $ $ $ Unearned net loan fees Net loans held for investment $

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income	9 Months Ended
	Sep. 30, 2016
Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income (Loss)	6. Accumulated Other Comprehensive Income The following table provides information on reclassifications out of accumulated other comprehensive income: Three months ended Nine months ended September 30, September 30, AOCI component (in thousands) 2016 2015 2016 2015 Line item in Condensed Consolidated Statements of Income Available for sale securities: Realized gain (loss) $ $ $ $ Net gain on securities, other assets and OREO Taxes Provision for income taxes Subtotal Held to maturity securities: Amortization of net unrealized gain on HTM securities Interest on taxable / nontaxable securities Taxes Provision for income taxes Subtotal Cash flow hedges: Loans Interest and fees on loans Debt Interest on subordinated debentures and notes payable Realized loss Taxes Provision for income taxes Subtotal Total reclassifications out of AOCI $ $ $ $ The following table provides the beginning and ending balances of AOCI and changes during the nine months ended September 30, 2016. Accumulated other comprehensive income (in thousands) Available for sale securities Held to maturity securities Cash flow hedges Total Balance at December 31, 2015 $ $ $ $ Other comprehensive income (loss) items - Reclassifications Other comprehensive loss, net of tax Balance at September 30, 2016 $ $ $ $

Derivatives

Derivatives	9 Months Ended
	Sep. 30, 2016
Derivatives
Derivatives	7. Derivatives ASC 815 contains the authoritative guidance on accounting and reporting standards for derivative instruments, including certain derivative instruments embedded in other contracts, and hedging activities. As required by ASC 815, the Company records all derivatives on the consolidated balance sheets at fair value. The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and unknown cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to certain variable-rate loan assets and variable-rate borrowings. The Company also enters into derivative financial instruments to protect against adverse changes in fair value on fixed-rate loans. The Company’s objective in using derivatives is to minimize the impact of interest rate fluctuations on the Company’s interest income and expense. To accomplish this objective, the Company uses interest rate swaps as part of its cash flow hedging strategy. The Company also offers an interest rate hedge program that includes various derivative products, including swaps, to assist its customers in managing their interest rate risk profile. In order to eliminate the interest rate risk associated with offering these products, the Company enters into derivative contracts with third parties to offset the customer contracts. These customer accommodation interest rate swap contracts are not designated as hedging instruments. The Company has also expanded its product offering by adding international banking products, which expose the Company to foreign exchange-rate risk. The Company utilizes foreign exchange forward contracts to manage the risk associated with fluctuation in foreign exchange rates. The Company has agreements with its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, including default where repayment of the indebtedness has not been accelerated by the lender, then the Company could also be declared in default on its derivative obligations. Also, the Company has agreements with certain of its derivative counterparties that contain a provision where if the Bank fails to maintain its status as a well or adequately capitalized institution, then the counterparty could terminate the derivative positions and the Company would be required to settle its obligations under the agreements. At September 30, 2016, the fair value of derivatives in a net liability position, including accrued interest but excluding any adjustment for nonperformance risk, related to these agreements was $16.9 million. The Company has minimum collateral posting thresholds with certain of its derivative counterparties and has posted collateral of $15.7 million against its obligations under these agreements. At September 30, 2016, the Company was not in default under any of its debt or capitalization covenants. The table below presents the fair value of the Company’s derivative financial instruments as well as the classification within the Condensed Consolidated Balance Sheets. Asset derivatives Liability derivatives Fair value at Fair value at Balance sheet September 30, December 31, Balance sheet September 30, December 31, (in thousands) classification 2016 2015 classification 2016 2015 Derivatives designated as hedging instruments under ASC 815: Cash flow hedge - interest rate swap Other assets $ - $ Accrued interest and other liabilities $ $ Fair value hedge - interest rate swap Other assets $ - $ Accrued interest and other liabilities $ $ Derivatives not designated as hedging instruments under ASC 815: Interest rate swap Other assets $ $ Accrued interest and other liabilities $ $ Foreign exchange forward contracts Other assets $ $ Accrued interest and other liabilities $ $ The tables below include information about financial instruments that are eligible to offset as required by ASU No. 2011-11, Disclosures about Offsetting Assets and Liabilities . At September 30, 2016 Assets Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives not designated as hedges (1) $ $ - $ $ $ - $ Total $ $ - $ $ $ - $ At September 30, 2016 Liabilities Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ $ - $ $ - $ $ - Derivatives not designated as hedges (2) - Securities sold under agreements to repurchase (3) - - - Total $ $ - $ $ $ $ At December 31, 2015 Assets Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ $ - $ $ $ - $ Derivatives not designated as hedges (1) - - Total $ $ - $ $ $ - $ At December 31, 2015 Liabilities Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ $ - $ $ $ $ - Derivatives not designated as hedges (2) - Securities sold under agreements to repurchase (3) - - - Total $ $ - $ $ $ $ (1) Included in other assets. (2) Included in accrued interest and other liabilities. (3) Separately stated in the Condensed Consolidated Balance Sheets. Cash Flow Hedges of Interest Rate Risk — For hedges of the Company’s variable-rate loan assets, interest rate swaps designated as cash flow hedges involve the receipt of fixed-rate amounts from a counterparty in exchange for the Company making variable-rate payments over the life of the agreements without exchange of the underlying notional amount. During the first quarter of 2016, the Company terminated five interest rate swaps with a notional value of $75.0 million that had fixed the interest rate on a portion of its 1-Month LIBOR loan portfolio. Upon termination, the Company had an unrealized gain of $1.3 million in AOCI. The unrealized gain will continue to be reported in AOCI, and will be reclassified to interest income over a period of three years. In October 2016, the Company entered into two interest rate swaps to hedge the risk of changes in cash flow on its LIBOR-based loan portfolio. The interest rate swaps have a weighted average term of six years and have a combined notional value of $100.0 million. The Company will pay a variable rate based on 1-month LIBOR and receive a weighted average fixed-rate of 1.23%. For hedges of the Company’s variable-rate borrowings, interest rate swaps designated as cash flow hedges involve the receipt of variable-rate amounts from a counterparty in exchange for the Company making fixed-rate payments. The Company has executed a series of interest rate swap transactions in order to fix the effective interest rate for payments due on its junior subordinated debentures with the objective of reducing the Company’s exposure to adverse changes in cash flows relating to payments on its LIBOR-based floating rate debt. The swaps have remaining maturities from four to eight years. Select critical terms of the cash flow hedges are as follows: (in thousands) Notional Fixed rate Termination date Hedged item - Junior subordinated debentures issued by: CoBiz Statutory Trust I $ % March 17, 2022 CoBiz Capital Trust II $ % April 23, 2020 CoBiz Capital Trust III $ % March 30, 2024 Based on the Company’s ongoing assessments (including at inception of the hedging relationship), it is probable that there will be sufficient variable interest payments through the maturity date of the swaps. The Company also monitors the risk of counterparty default on an ongoing basis. The Company uses the “Hypothetical Derivative” method described in ASC 815 , for both prospective and retrospective assessments of hedge effectiveness on a quarterly basis. The Company also uses this methodology to measure hedge ineffectiveness each period. The effective portion of changes in the fair value of derivatives designated and that qualify as cash flow hedges is recorded in AOCI and is subsequently reclassified into earnings in the period that the hedged forecasted transaction affects earnings. The ineffective portion of the change in fair value of the derivatives is recognized directly in earnings. The Company’s derivatives did not have any hedge ineffectiveness recognized in earnings during the three and nine months ended September 30, 2016 and 2015. Amounts reported in AOCI related to derivatives will be reclassified to interest income/expense as interest payments are received/paid on the Company’s variable-rate assets/liabilities. During the next 12 months, the Company estimates that $1.5 million will be reclassified as an increase to interest expense and $0.6 million will be reclassified as an increase to interest income. Fair Value Hedges of Fixed-Rate Assets – The Company is exposed to changes in the fair value of certain of its fixed-rate assets due to changes in benchmark interest rates based on LIBOR. The Company uses interest rate swaps to manage its exposure to changes in fair value on certain fixed-rate loans. Interest rate swaps designated as fair value hedges involve the receipt of variable-rate payments from a counterparty in exchange for the Company’s fixed-rate payments over the life of the agreements without the exchange of the underlying notional amount. Certain interest rate swaps met the criteria to qualify for the shortcut method of accounting. Under the shortcut method of accounting, no ineffectiveness is assumed. For interest rate swaps not accounted for under the shortcut method, the Company performs ongoing retrospective and prospective effectiveness assessments (including at inception) using a regression analysis to compare periodic changes in fair value of the swaps to periodic changes in fair value of the fixed-rate loans attributable to changes in the benchmark interest rate. At September 30, 2016, the Company had interest rate swaps with a notional amount of $63.4 million used to hedge the change in the fair value of 11 commercial loans. For derivatives that are designated and qualify as fair value hedges that are not accounted for under the shortcut method, the gain or loss on the derivative as well as the gain or loss on the hedged item attributable to the hedged risk are recognized in earnings. The net amount recognized in “Other income” in the Condensed Consolidated Statements of Income during the three and nine months ended September 30, 2016 representing hedge ineffectiveness was not material and $0.3 million, respectively. During the three and nine months ended September 30, 2015, hedge ineffectiveness was immaterial. Non-designated Hedges — Derivatives not designated as hedges are not speculative and primarily result from a service the Company provides to its customers. The Company executes interest rate swaps with commercial banking customers to facilitate their respective risk management strategies. Those interest rate swaps are simultaneously hedged by offsetting interest rate swaps that the Company executes with a third party, such that the Company minimizes its net risk exposure resulting from such transactions. As the interest rate swaps associated with this program do not meet the strict hedge accounting requirements, changes in the fair value of both the customer swaps and the offsetting swaps are recognized directly in earnings. At September 30, 2016, the Company had 90 interest rate swaps with an aggregate notional amount of $210.6 million related to this program. During the three and nine months ended September 30, 2016 and 2015, gains and losses arising from changes in the fair value of these swaps, which are included in “Other income,” in the Condensed Consolidated Statements of Income, were immaterial. The Company’s product offerings also include international banking products that create foreign currency exchange-rate risk exposure. At September 30, 2016, the Company’s foreign currency holdings included British pounds, Euro, Swiss Franc, Japanese Yen, Mexican Pesos, and New Zealand, Australian and Canadian dollars. In order to economically reduce the risk associated with the fluctuation of foreign exchange rates, the Company utilizes short-term foreign exchange forward contracts to lock in exchange rates so the gain or loss on the forward contracts approximately offsets the transaction gain or loss. These contracts are not designated as hedging instruments. Ineffectiveness in the economic hedging relationship may occur as the foreign currency holdings are revalued based upon changes in the currency’s spot rate, while the forward contracts are revalued using the currency’s forward rates. Forward contracts in gain positions are recorded at fair value in ‘Other assets” and, forward contracts in loss positions are recorded in “Accrued interest and other liabilities” in the Condensed Consolidated Balance Sheets. Net changes in the fair value of the forward contracts are recognized through earnings, disclosed as ‘other’ noninterest income in the Condensed Consolidated Statements of Income. At September 30, 2016, the Company had forward contracts with a notional amount of $5.5 million that mature in less than one year. Net gains recognized and included in “Other income” in the Condensed Consolidated Statements of Income during the three and nine months ended September 30, 2016 and 2015 on foreign exchange forward contracts was $0.1 million and $0.3 million, respectively.

Borrowed Funds

Borrowed Funds	9 Months Ended
	Sep. 30, 2016
Borrowed Funds
Borrowed Funds	8. Borrowed Funds Securities sold under agreements to repurchase at September 30, 2016 and December 31, 2015 are summarized below. September 30, December 31, (in thousands) 2016 2015 Securities sold under agreements to repurchase (secured by pledge of principally mortgage-backed securities with an estimated fair value of $53,156 and $49,882, respectively) $ $ The Company enters into sales of securities under agreements to repurchase. The amounts received under these agreements represent short-term borrowings and are reflected as a liability in the Condensed Consolidated Balance Sheets. The securities underlying these agreements are included in investment securities in the Condensed Consolidated Balance Sheets. At September 30, 2016, all securities sold under agreements to repurchase had a maturity date of less than three months. The Company has no control over the market value of the securities, which fluctuates due to market conditions. However, the Company is obligated to promptly transfer additional securities if the market value of the securities falls below the repurchase agreement price. The Company manages this risk by maintaining an unpledged securities portfolio that it believes is sufficient to cover a decline in the market value of the securities sold under agreements to repurchase. During the second quarter of 2016, the Company renewed a revolving Line of Credit (LOC) agreement with an aggregate principal sum of up to $20.0 million bearing interest at 1-month LIBOR plus 225 basis points. The Company pays a quarterly commitment fee of 0.35% per annum on the unused portion of the LOC. The LOC matures May 2017, at which time any outstanding amounts are due and payable. Proceeds from the LOC will be used for general corporate purposes and backup liquidity. Although the LOC is unsecured, the Company has agreed not to sell, pledge or transfer any part of its right, title or interest in the Bank. At September 30, 2016 and December 31, 2015, there was no amount outstanding on the LOC.

Employee Benefit and Stock Comp

Employee Benefit and Stock Compensation Plans	9 Months Ended
	Sep. 30, 2016
Employee Benefit and Stock Compensation Plans
Employee Benefit And Stock Compensation Plans	9. Employee Benefit and Stock Compensation Plans Stock Options and Awards During the three and nine months ended September 30, 2016, the Company recognized stock-based compensation expense of $0.7 million and $2.5 million, respectively. As discussed in Note 2 – Recent Accounting Pronouncements, the Company adopted the amendments to share-based compensation accounting in ASU 2016-09 in the first quarter of 2016. In accordance with ASU 2016-09, beginning in 2016 the Company elected a policy to account for forfeitures as they occur. The following table summarizes changes in option awards during the nine months ended September 30, 2016: Weighted average Shares exercise price Outstanding at December 31, 2015 $ Granted Exercised Forfeited Outstanding at September 30, 2016 $ Exercisable at September 30, 2016 $ The weighted average grant date fair value of options granted during the nine months ended September 30, 2016 was $2.29. The following table summarizes changes in stock awards during the nine months ended September 30, 2016. Weighted average Shares grant date fair value Unvested at December 31, 2015 $ Granted Vested Forfeited Unvested at September 30, 2016 $ At September 30, 2016, there was $4.1 million of total unrecognized compensation expenses related to unvested share-based compensation arrangements granted under the plans. The expense is expected to be recognized over a weighted-average period of 1.9 years.

Leases

Leases	9 Months Ended
	Sep. 30, 2016
Leases
Leases	10. Leases The Company has various operating lease agreements for office space. In January 2016, the Company entered into a new lease for facilities located at 1401 Lawrence Street, Denver, Colorado. The leased space will become the new headquarters for the Company and includes 44,010 square feet of office space and 4,000 square feet of ground level retail space for a banking facility. The Company took possession of the space in June 2016 and expects to relocate and commence operations from that location in December 2016. The lease term is for 12 years with rents escalating 2% annually. Scheduled rents for the new headquarters lease are included in the five year lease obligations table below. In addition to the new headquarters lease, the Company extended the lease for its current headquarters to retain the space through December 2016. Rents under the extension are included in the table below. (in thousands) At September 30, 2016 2016 (remainder) $ 2017 2018 2019 2020 Thereafter Total $

Segments

Segments	9 Months Ended
	Sep. 30, 2016
Segments
Segments	11. Segments The Company’s operating segments consist of Commercial Banking, Fee-Based Lines and Corporate Support and Other. The financial information for the Commercial Banking and Fee-Based Lines segments reflect activities which are specifically identifiable or which are allocated based on an internal allocation method. The Corporate Support and Other segment includes activities that are not directly attributable to the other reportable segments including centralized bank operations and the activities of the Parent. The following tables report the results of operations for the three and nine months ended September 30, 2016 and 2015 by segment. Three months ended September 30, 2016 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ $ - $ $ Total interest expense Provision for loan losses - Noninterest income Noninterest expense Management fees and allocations, net of tax - Provision (benefit) for income taxes Net income (loss) $ $ $ $ Nine months ended September 30, 2016 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ $ $ $ Total interest expense Provision for loan losses - Noninterest income Noninterest expense Management fees and allocations, net of tax - Provision (benefit) for income taxes Net income (loss) $ $ $ $ Three months ended September 30, 2015 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ $ $ $ Total interest expense Provision for loan losses - Noninterest income Noninterest expense Management fees and allocations, net of tax - Provision (benefit) for income taxes Net income (loss) $ $ $ $ Nine months ended September 30, 2015 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ $ $ $ Total interest expense Provision for loan losses - Noninterest income Noninterest expense Management fees and allocations, net of tax - Provision (benefit) for income taxes Net income (loss) from continuing operations $ $ $ $ Net loss from discontinued operations - - Net income (loss) $ $ $ $

Fair Value Measurements

Fair Value Measurements	9 Months Ended
	Sep. 30, 2016
Fair Value Measurements
Fair Value Measurements	12. Fair Value Measurements ASC 820 emphasizes that fair value is a market-based measurement, not an entity-specific measurement. Therefore, a fair value measurement should be determined based on the assumptions that market participants would use in pricing an asset or liability. As a basis for considering market participant assumptions in fair value measurements, ASC 820 establishes a fair value hierarchy that distinguishes between market participant assumptions based on market data obtained from sources independent of the reporting entity (observable inputs that are classified within Levels 1 and 2 of the hierarchy) and the reporting entity’s own assumptions about market participant assumptions (unobservable inputs classified within Level 3 of the hierarchy). · Level 1 inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access at the measurement date. · Level 2 inputs are inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs may include quoted prices for similar assets and liabilities in active markets, as well as inputs that are observable for the asset or liability (other than quoted prices), such as interest rates, foreign exchange rates and yield curves that are observable at commonly quoted intervals. · Level 3 inputs are unobservable inputs for the asset or liability, which is typically based on an entity’s own assumptions, as there is little, if any, related market activity. In instances where the determination of the fair value measurement is based on inputs from different levels of the fair value hierarchy, the level in the fair value hierarchy within which the entire fair value measurement falls is based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability. The Company evaluates fair value measurement inputs on an ongoing basis in order to determine if there is a change of sufficient significance to warrant a transfer between levels. For example, changes in market activity or the addition of new unobservable inputs could, in the Company’s judgment, cause a transfer to either a higher or lower level. Assets and liabilities measured on a recurring basis A description of the valuation methodologies used for financial instruments measured at fair value on a recurring basis, as well as the general classification of such instruments pursuant to the valuation hierarchy, is set forth below. Available for sale securities – At September 30, 2016, the Company held, as part of its investment portfolio, available for sale securities reported at fair value consisting of municipal securities, corporate debt securities, and TPS. The fair value of the majority of municipal securities is determined using widely accepted valuation techniques including matrix pricing and broker-quote based applications. Inputs include benchmark yields, reported trades, issuer spreads, and other relevant items. As a result, the Company has determined that these valuations fall within Level 2 of the fair value hierarchy. The Company also holds TPS that are recorded at fair value based on unadjusted quoted market prices for identical securities in an active market. The majority of the TPS are actively traded in the market and as a result, the Company has determined that the valuation of these securities falls within Level 1 of the fair value hierarchy. The Company also holds certain TPS and corporate debt securities for which unadjusted market prices are not available or the markets are not active and are therefore classified as Level 2 or Level 3. In the second quarter of 2016, the Company transferred a TPS from Level 2 to Level 3 due to the lack of recent market activity. The Company uses broker-dealer quotes, valuations based on similar but not identical securities, or the most recent market trade (which may not be current) to price these securities. Total net unrealized gain recognized in AOCI at September 30, 2016 on TPS Level 3 securities was immaterial. Derivative financial instruments – The Company uses interest rate swaps as part of its cash flow strategy to manage its interest rate risk. The valuation of these instruments is determined using widely accepted valuation techniques as discussed further below. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. Pursuant to guidance in ASC 820, credit valuation adjustments are incorporated into the valuation to appropriately reflect both the Company’s own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements. In adjusting the fair value of its derivative contracts for the effect of nonperformance risk, the Company has considered the impact of netting and any applicable credit enhancements, such as collateral postings and thresholds. The Company uses Level 2 and Level 3 inputs to determine the valuation of its derivatives portfolio. The valuation of derivative instruments is determined using widely accepted valuation techniques including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs (Level 2 inputs), including interest rate curves and implied volatilities. The estimates of fair value are made using a standardized methodology that nets the discounted expected future cash receipts and cash payments (based on observable market inputs). Level 3 inputs include the credit valuation adjustments which use estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. At September 30, 2016 and December 31, 2015, the Company assessed the impact of the Level 3 inputs on the overall derivative valuations in terms of the significance of the credit valuation adjustments in basis points and as a percentage of the overall derivative portfolio valuation and the overall notional value. The Company’s assessment determined that credit valuation adjustments were not significant to the overall valuation of the portfolio. In addition, the significance of the credit value adjustments and overall derivative portfolio to the Company’s financial statements was considered. As a result of the insignificance of the credit value adjustments to the derivative portfolio valuations and the Company’s financial statements, the Company classified the derivative valuations in their entirety in Level 2. The Company uses foreign exchange forward contracts to mitigate exchange-rate risk arising from the Company’s foreign currency holdings to support its international banking product offering. Fair value measurements of these assets or liabilities are priced based on spot and forward foreign currency rates and the credit worthiness of the contract counterparty. These contracts are classified in Level 2. The following tables present the Company’s assets and liabilities measured at fair value on a recurring basis at September 30, 2016 and December 31, 2015, aggregated by the level in the fair value hierarchy within which those measurements fall. Fair value measurements using: Quoted prices in Significant other Significant other active markets for observable observable Balance at identical assets inputs inputs (in thousands) September 30, 2016 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ $ $ $ Corporate debt securities - - Municipal securities - - Total available for sale securities $ $ $ $ Derivatives: Fair value hedges $ - $ - $ - $ - Non-designated hedges - - Foreign exchange forward contracts - - Total derivative assets $ $ - $ $ - Liabilities Derivatives: Cash flow hedges $ $ - $ $ - Fair value hedges - - Non-designated hedges - - Foreign exchange forward contracts - - Total derivative liabilities $ $ - $ $ - Fair value measurements using: Quoted prices in Significant other Significant other active markets for observable observable Balance at identical assets inputs inputs (in thousands) December 31, 2015 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ $ $ $ Corporate debt securities - - Municipal securities - - Total available for sale securities $ $ $ $ Derivatives: Cash flow hedges $ $ - $ $ - Fair value hedges - - Non-designated hedges - - Foreign exchange forward contracts - - Total derivative assets $ $ - $ $ - Liabilities Derivatives: Cash flow hedges $ $ - $ $ - Fair value hedge - - Non-designated hedges - - Foreign exchange forward contracts - - Total derivative liabilities $ $ - $ $ - A reconciliation of the beginning and ending balances of assets measured at fair value, on a recurring basis, using Level 3 inputs follows: Three months ended Nine months ended September 30, September 30, (in thousands) 2016 2015 2016 2015 Beginning balance $ $ $ $ Transfers - - - Net accretion Sales / calls / maturities - - - Unrealized gain included in comprehensive income Ending balance $ $ $ $ Assets and liabilities measured on a nonrecurring basis Fair value is used on a nonrecurring basis to evaluate certain financial assets and financial liabilities in specific circumstances. Similarly, fair value is used on a nonrecurring basis for nonfinancial assets and nonfinancial liabilities such as foreclosed assets, other real estate owned, intangible assets, nonfinancial assets and liabilities evaluated in a goodwill impairment analysis and other nonfinancial assets measured at fair value for purposes of assessing impairment. A description of the valuation methodologies used for financial and nonfinancial assets and liabilities measured at fair value, as well as the general classification of such assets and liabilities pursuant to the valuation hierarchy, is set forth below. Impaired loans – Certain collateral-dependent impaired loans are reported at the fair value of the underlying collateral. Impairment is measured based on the fair value of the collateral, which is typically derived from appraisals that take into consideration prices in observed transactions involving similar assets and similar locations. Each appraisal is updated on an annual basis, either through a new appraisal or through the Company’s comprehensive internal review process. Appraised values are reviewed and monitored internally and fair value is assessed at least quarterly or more frequently when circumstances occur that indicate a change in fair value has occurred. The Company classified impaired loans as Level 3. Other real estate owned (OREO) – OREO represents real property taken by the Company either through foreclosure or through a deed in lieu thereof from the borrower. The fair value of OREO is based on property appraisals adjusted at management’s discretion to reflect a further decline in the fair value of properties since the time the appraisal analysis was performed. Therefore, the inputs used to determine the fair value of OREO fall within Level 3. The Company may include within OREO other repossessed assets received as partial satisfaction of a loan. Other repossessed assets are not material and do not typically have readily determinable market values and are considered Level 3 inputs. The following table presents the Company’s assets measured at fair value on a nonrecurring basis at the dates specified in the following table, aggregated by the level in the fair value hierarchy within which those measurements fall. Fair value measurements using: Quoted prices in Significant other Significant other active markets for observable observable identical assets inputs inputs (in thousands) Total (Level 1) (Level 2) (Level 3) At September 30, 2016 Impaired loans $ $ - $ - $ OREO $ $ - $ - $ At December 31, 2015 Impaired loans $ $ - $ - $ OREO $ $ - $ - $ Gains and losses, which include the provision for losses on impaired loans, recorded in relation to assets and liabilities measured on a nonrecurring basis are presented below: Gain for the three months ended Gain for the nine months ended September 30, September 30, (in thousands) 2016 2015 2016 2015 Impaired loans $ $ $ $ OREO $ - $ $ - $ In accordance with ASC 310, the fair value of OREO recorded as an asset is reduced by estimated selling costs. The following table is a reconciliation of the fair value measurement of OREO disclosed pursuant to ASC 820 to the amount recorded on the Condensed Consolidated Balance Sheets: At At (in thousands) September 30, 2016 December 31, 2015 OREO recorded at fair value $ $ Estimated selling costs OREO $ $ Below is a summary of OREO transactions for the nine months ended September 30, 2016: (in thousands) OREO Beginning OREO balance $ OREO sales - Valuation adjustments - Ending OREO balance $ The following tables provide information describing the valuation processes used to determine recurring and nonrecurring fair value measurements categorized within Level 3 of the fair value hierarchy at September 30, 2016 and December 31, 2015. At September 30, 2016 Fair Value Weighted Category (in thousands) Valuation Technique Unobservable Input Average Range Trust preferred securities $ Market approach Discount to carrying value using broker quotes or observable prices on similar securities 14 % 1% to 20% Impaired loans: Commercial $ Sales comparison (1) Management discount for asset type 33 % 0% - 76% Commercial Sales comparison (2) Sales comparison adjustments (38) % NA Real estate - mortgage Sales comparison (2) Sales comparison adjustments 16 % 9% - 18% Consumer Sales comparison (2) Sales comparison adjustments 10 % NA Total impaired loans $ OREO: Commercial $ Property appraisals (2) Management discount for property type and recent market volatility 0 % NA Construction & land Property appraisals (2) Management discount for property type and recent market volatility 17 % NA Total OREO $ At December 31, 2015 Fair Value Weighted Category (in thousands) Valuation Technique Unobservable Input Average Range Trust preferred securities $ Market approach Discount to carrying value using broker quotes or observable prices on similar securities 15 % 1% to 18% Impaired loans: Commercial $ Sales comparison (1) Management discount for asset type 47 % 0% to 81% Commercial Sales comparison (2) Sales comparison adjustments (32) % NA Real estate - mortgage Sales comparison (2) Sales comparison adjustments 12 % (15)% to 17% Construction & land Sales comparison (2) Sales comparison adjustments (24) % NA Consumer Sales comparison (2) Sales comparison adjustments 11 % (2)% to 14% Total impaired loans $ OREO: Commercial $ Property appraisals (2) Management discount for property type and recent market volatility 0 % 0% Construction & land Property appraisals (2) Management discount for property type and recent market volatility 17 % NA Total OREO $ (1) Discount represents management’s discounts applied to market valuation of various business asset types including accounts receivable and other commercial assets. (2) The fair value of OREO and collateral-dependent impaired loans is based on third-party property appraisals. The majority of the appraisals utilize a single valuation approach or a combination of approaches including a market approach, where prices and other relevant information generated by market transactions involving identical or comparable properties are used to determine fair value. Appraisals may include an ‘as is’ sales comparison approach and an ‘upon completion’ valuation approach. Adjustments are routinely made in the appraisal process by third-party appraisers to adjust for differences between the comparable sales and income data. Adjustments also result from the consideration of relevant economic and demographic factors with the potential to affect property values. Also, prospective values are based on the market conditions which exist at the date of inspection combined with informed forecasts based on current trends in supply and demand for the property types under appraisal. For sales comparisons, positive adjustments disclosed in these tables represent increases and negative adjustments represent decreases in fair value. The following table includes the estimated fair value of the Company’s financial instruments. The methodologies for estimating the fair value of financial assets and financial liabilities measured at fair value on a recurring and nonrecurring basis are discussed above. The methodologies for estimating the fair value for other financial assets and financial liabilities are discussed below. The estimated fair value amounts have been determined by the Company using available market information and appropriate valuation methodologies. However, considerable judgment is required to interpret market data in order to develop the estimates of fair value. Accordingly, the estimates presented herein are not necessarily indicative of the amounts the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts at September 30, 2016 and December 31, 2015. September 30, 2016 December 31, 2015 Carrying Estimated Carrying Estimated (in thousands) value fair value value fair value Financial assets: Cash and cash equivalents $ $ $ $ Investment securities available for sale Investment securities held to maturity Other investments Loans — net Accrued interest receivable Derivatives Financial liabilities: Deposits $ $ $ $ Securities sold under agreements to repurchase Other short-term borrowings Accrued interest payable Subordinated notes payable Junior subordinated debentures Derivatives The fair value estimation methodologies utilized by the Company for financial instruments and the classification level within the fair value hierarchy that those instruments fall are summarized as follows: Cash and cash equivalents — The carrying amount of cash and cash equivalents is a reasonable estimate of fair value which is classified as Level 2. Other investments — Included in this category are the Company’s investments in other equity method investments. Due to restrictions on transferability, it is not practical to estimate fair value on the Bank stocks which are excluded from the table above. The fair value of other equity method investments approximates fair value and is classified as Level 2. Loans — The fair value of loans is estimated by discounting future contractual cash flows using estimated market rates at which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. In computing the estimate of fair value for all loans, the estimated cash flows and/or carrying value have been reduced by specific and general reserves for loan losses. The fair value of loans disclosed in the table above, which is not the exit price, is classified as Level 3 within the fair value hierarchy. Accrued interest receivable/payable — The fair value of accrued interest receivable/payable approximates the carrying amount due to the short-term nature of these amounts and is classified in the same level hierarchy as the underlying assets/liabilities. Deposits — The fair value of certificates of deposit is estimated by discounting the expected life using an index of the U.S. Treasury curve. Non-maturity deposits are reflected at their carrying value for purposes of estimating fair value. The fair value of all deposits is classified as Level 2. Securities sold under agreements to repurchase — Estimated fair value is based on discounting cash flows and is classified as Level 2. Short-term borrowings — The estimated fair value of short-term borrowings approximates their carrying value, due to their short-term nature and is classified as Level 2. Subordinated notes payable — The estimated fair value of subordinated notes payable is based on discounting cash flows for comparable instruments and is classified as Level 3. Junior subordinated debentures — The estimated fair value of junior subordinated debentures approximates their carrying value, due to the variable interest rate paid on the debentures and is classified as Level 2. Commitments to extend credit and standby letters of credit — The Company’s off-balance sheet commitments are funded at current market rates at the date they are drawn upon. It is management’s opinion that the fair value of these commitments would approximate their carrying value, if drawn upon, and are classified as Level 3. The fair value estimates presented herein are based on pertinent information available to management at September 30, 2016 and December 31, 2015. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, such amounts have not been comprehensively revalued for purposes of these financial statements since that date and, therefore, current estimates of fair value may differ significantly from the amounts presented herein.

Regulatory Matters

Regulatory Matters	9 Months Ended
	Sep. 30, 2016
Regulatory Matters
Regulatory Matters	13. Regulatory Matters Beginning in 2016, a Capital Conservation Buffer (CCB) requirement became effective for banking organizations. The CCB is designed to establish a capital range above minimum requirements to insulate banks from periods of stress and impose constraints on dividends, share repurchases and discretionary bonus payments when capital levels fall below prescribed levels. The minimum CCB in 2016 is 0.625% and increases 0.625% annually through 2019 to 2.5%. The following table presents the regulatory capital ratios of the Bank and Holding Company, including regulatory thresholds, at September 30, 2016. At September 30, 2016 Capitalized Ratio Bank Company Minimum ratio (in thousands) Ratios Ratios Well (1) plus fully phased-in CCB Common equity tier 1 capital % % % % Tier 1 capital % % % % Total capital % % % % Tier 1 leverage % % % % (1) The ratios for the well-capitalized requirement are only applicable to the Bank. However, the Company manages its capital position as if the requirement applies to the consolidated entity and has presented the ratios as if they also applied to the Company.

Supplemental Financial Data

Supplemental Financial Data	9 Months Ended
	Sep. 30, 2016
Supplemental Financial Data
Supplemental Financial Data	14. Supplemental Financial Data Other noninterest income and other noninterest expense as shown in the Condensed Consolidated Statements of Income for the three and nine months ended September 30, 2016 and 2015 are detailed in the following tables. Three months ended Nine months ended Other noninterest income September 30, September 30, (in thousands) 2016 2015 2016 2015 Loan fees $ $ $ $ Other customer service fees Bank-owned life insurance Equity method investments Interest rate swaps - Other Total $ $ $ $ Three months ended Nine months ended Other noninterest expense September 30, September 30, (in thousands) 2016 2015 2016 2015 Marketing and business development $ $ $ $ Service contracts Professional fees Office supplies and delivery Other Total $ $ $ $

Nature of Operations and Sign21

Nature of Operations and Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2016
Nature of Operations and Significant Accounting Policies
Use of Estimates	Use of Estimates – In preparing its financial statements, the Company is required to make estimates and assumptions that affect the reported amount of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates.
Basis of Presentation	Basis of Presentation —These Condensed Consolidated Financial Statements and notes thereto should be read in conjunction with, and are qualified in their entirety by, the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the U.S. Securities and Exchange Commission (SEC). The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the instructions to Form 10-Q. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. In the opinion of management, all adjustments (consisting only of normally recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three and nine months ended September 30, 2016, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2016. The Condensed Consolidated Financial Statements include entities in which the Parent has a controlling financial interest. These entities include: the Bank; CoBiz Insurance, Inc.; and CoBiz IM. Intercompany balances and transactions are eliminated in consolidation. The Company determines whether it has a controlling financial interest in an entity by first evaluating whether the entity is a voting interest entity or a variable interest entity (VIE). The voting interest model is used when the equity investment is sufficient to absorb the expected losses and the equity investment has all of the characteristics of a controlling financial interest. Under the voting interest model, the party with the controlling voting interest consolidates the legal entity. The VIE model is used when any of the following conditions exist: the equity investment at risk is not sufficient to finance the entity’s activities without additional subordinated financial support; the holders of the equity investment do not have a controlling voting interest; or the holders of the equity investment are not obligated to absorb the expected losses or residual returns of the legal entity. An enterprise is considered to have a controlling financial interest of a VIE if it has both the power to direct the activities that most significantly impact economic performance and the obligation to absorb losses, or receive benefits, that are significant to the VIE. An enterprise that has a controlling financial interest is considered the primary beneficiary and must consolidate the VIE. The Company was not the primary beneficiary of a VIE at September 30, 2016 or December 31, 2015. Certain reclassifications have been made to prior years’ Condensed Consolidated Financial Statements and related notes to conform to the current year presentation.
Cash and Cash Equivalents	Cash and Cash Equivalents — The Company considers all liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include amounts that the Company is required to maintain at the Federal Reserve Bank of Kansas City to meet certain regulatory reserve balance requirements. The following table shows supplemental disclosures of certain cash and noncash items: Nine months ended September 30, (in thousands) 2016 2015 Cash paid during the period for: Interest $ $ Income taxes Other noncash activities: Available for sale securities transferred to held to maturity $ - $ Loans transferred to held for sale
Investments	Investments — The Company classifies its investment securities as held to maturity, available for sale or trading, according to management’s intent. Investment security transactions are recorded on a trade date basis. At September 30, 2016 and December 31, 2015, the Company had no trading securities. Available for sale securities consist of bonds, notes and debentures (including corporate debt and trust preferred securities (TPS)) not classified as held to maturity securities and are reported at fair value as determined by quoted market prices. Unrealized holding gains and losses, net of tax, are reported as a net amount in AOCI until realized. Investment securities held to maturity consist of residential mortgage-backed securities (MBS), bonds, notes and debentures for which the Company has the intent and ability to hold to maturity and are reported at cost, adjusted for amortization or accretion of premiums and discounts. Premiums and discounts, adjusted for prepayments as applicable, are recognized in interest income. Other than temporary declines in the fair value of individual investment securities held to maturity and available for sale are charged against earnings. Gains and losses on disposal of investment securities are determined using the specific-identification method. Other-than-temporary-impairment (OTTI) on debt securities is separated between the amount that is credit related (credit loss component) and the amount due to all other factors. The credit loss component is recognized in earnings and is the difference between a security’s amortized cost basis and the discounted present value of expected future cash flows. The amount due to all other factors is recognized in other comprehensive income (OCI).
Bank Stocks	Bank Stocks — Federal Home Loan Bank of Topeka (FHLB), Federal Reserve Bank and other correspondent bank stocks are accounted for under the cost method.
Loans Held for Investment	Loans Held for Investment — Loans that the Company has the intent and ability to hold for the foreseeable future or until maturity or pay-off are reported at their outstanding principal balances adjusted for any charge-offs, the allowance for loan losses, deferred fees and costs on originated loans, and unamortized premiums or discounts on purchased loans. Interest is accrued and credited to income daily based on the principal balance outstanding. The accrual of interest income is generally discontinued when a loan becomes 90 days past due as to principal and interest. When a loan is designated as nonaccrual, the current period’s accrued interest receivable is charged against current earnings while any portions relating to prior periods are charged against the allowance for loan losses. Interest payments received on nonaccrual loans are generally applied to the principal balance of the loan. Loans are returned to accrual status when all the principal and interest amounts contractually due are brought current and future payments are reasonably assured and there has been demonstrated performance in accordance with contractual terms. The Company may elect to continue the accrual of interest when the loan is in the process of collection and the realizable value of collateral is sufficient to cover the principal balance and accrued interest.
Loans Held for Sale	Loans Held for Sale — Loans held for sale include loans the Company has demonstrated the ability and intent to sell. Loans held for sale are primarily nonperforming loans. Loans held for sale are carried at the lower of cost or fair value and are evaluated on a loan-by-loan basis.
Impaired Loans	Impaired Loans — Impaired loans, with the exception of groups of smaller-balance homogenous loans that are collectively evaluated for impairment, are defined as loans for which, based on current information and events, it is probable that the Company will be unable to collect the scheduled payments of principal or interest when due according to the contractual terms of the loan agreement. Factors considered by management in determining impairment include payment status, collateral value, and the probability of collecting scheduled principal and interest payments when due. Loans that experience insignificant payment delays of less than 90 days and monthly payment shortfalls of less than 10% of the contractual payment on a consumer loan generally are not classified as impaired if the Company ultimately expects to recover its full investment. The Company determines the significance of payment delays and payment shortfalls on a case-by-case basis, taking into consideration all of the circumstances surrounding the loan and the borrower, including the length of the delay, the reasons for the delay, the borrower’s prior payment record, and the amount of the shortfall in relation to the principal and interest owed. Impairment is measured on a loan-by-loan basis by the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s obtainable market price or the fair value of the collateral if the loan is collateral dependent. Loans that are deemed to be impaired are evaluated in accordance with Accounting Standards Codification (ASC) Topic 310-10-35, Receivables – Subsequent Measurement (ASC 310) and ASC Topic 450-20, Loss Contingencies (ASC 450). Included in impaired loans are troubled debt restructurings. A troubled debt restructuring is a formal restructure of a loan where the Company, for economic or legal reasons related to the borrower’s financial difficulties, grants a concession to the borrower. The concessions may be granted in various forms, including but not limited to reduction in the stated interest rate, reduction in the loan balance or accrued interest, or extension of the maturity date. Troubled debt restructurings are evaluated in accordance with ASC Topic 310-40, Troubled Debt Restructurings by Creditors. Interest payments on impaired loans are typically applied to principal unless collectability of principal is reasonably assured. Loans that have been modified in a formal restructuring are typically returned to accrual status when there has been a sustained period of performance (generally six months) under the modified terms, the borrower has shown the ability and willingness to repay and the Company expects to collect all amounts due under the modified terms.
Loan Origination Fees and Costs	Loan Origination Fees and Costs — Loan fees and certain costs of originating loans are deferred and the net amount is amortized over the contractual life of the related loans in accordance with ASC Topic 310-20, Nonrefundable Fees and Other Costs.
Allowance for Loan Losses	Allowance for Loan Losses — The allowance for loan losses (ALL) is established as losses are estimated to have occurred through a provision for loan losses charged against earnings. Loan losses are charged against the allowance when management believes the uncollectability of a loan balance is confirmed. Subsequent recoveries, if any, are credited to the allowance. The ALL is evaluated on a regular basis by management and is based upon management’s periodic review of the collectability of the loans in light of historical experience, the nature and volume of the loan portfolio, adverse situations that may affect the borrower’s ability to repay, estimated value of any underlying collateral, and prevailing economic conditions. This evaluation is inherently subjective as it requires estimates that are susceptible to significant revision as new information becomes available.
Allowance for Credit Losses	Allowance for Credit Losses — The allowance for credit losses is established as losses are estimated to have occurred through a provision for credit losses charged to earnings. The allowance for credit losses represents management’s recognition of a separate reserve for off-balance sheet loan commitments and letters of credit. While the allowance for loan losses is recorded as a contra-asset to the loan portfolio on the Condensed Consolidated Balance Sheets, the allowance for credit losses is recorded under the caption “Accrued interest and other liabilities”. Although the allowances are presented separately on the balance sheets, any losses incurred from credit losses would be reported as a charge-off in the allowance for loan losses, as any loss would be recorded after the off-balance sheet commitment had been funded.
Bank-Owned Life Insurance (BOLI)	Bank-Owned Life Insurance (BOLI) – The Bank invested in BOLI policies to fund certain future employee benefit costs. The policies are recorded at net realizable value. Changes in the amount that could be realized and amounts realized from policy claims are recorded in the Condensed Consolidated Statements of Income as “Other income”.
Derivative Instruments	Derivative Instruments — Derivative financial instruments are accounted for at fair value. The Company utilizes interest rate swaps to hedge a portion of its exposure to interest rate changes. These instruments are accounted for as cash flow hedges, as defined by ASC Topic 815, Derivatives and Hedging (ASC 815). The Company also uses interest rate swaps to hedge against adverse changes in fair value on fixed-rate loans. These instruments are accounted for as fair value hedges in accordance with ASC 815. The net cash flows from these hedges are classified in operating activities within the Condensed Consolidated Statements of Cash Flows with the hedged items. The Company also has a derivative program that offers interest rate caps, floors, swaps and collars to customers of the Bank. The fair value amounts recognized for derivative instruments and the fair value amounts recognized for the right to reclaim or obligation to return cash collateral are not offset when represented under a master netting arrangement. The Company also uses foreign currency forward contracts (FX forwards) giving it the right to sell underlying currencies at specified future dates and predetermined prices in order to mitigate foreign exchange risk associated with long positions. FX forwards are carried at fair value with changes in value recognized in current earnings as the contracts are not designated as hedging instruments.
Fair Value Measurements	Fair Value Measurements — The Company measures financial assets, financial liabilities, nonfinancial assets and nonfinancial liabilities pursuant to ASC Topic 820, Fair Value Measurement (ASC 820). ASC 820 defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements.
Loss From Discontinued Operations, Net of Income Taxes	Loss From Discontinued Operations, Net of Income Taxes — During the first quarter of 2015, the Company ceased the operations of its investment banking subsidiary due to increasing regulatory compliance costs and to focus on activities that provide recurring revenue. Investment banking revenue was transactional and highly dependent on deal volume which could vary significantly from period to period.
Recent Accounting Pronouncements	In February 2016, the Financial Accounting Standard Board (FASB) issued Accounting Standard Update (ASU) 2016-02, Leases (Topic 842) (ASU 2016-02). ASU 2016-02 is intended to increase transparency and comparability among organizations by recognizing lease assets and liabilities on the balance sheet and disclosing key information about leasing arrangements. For public business entities, this ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2018. The Company is currently evaluating the effects of ASU 2016-02 on its financial statements and disclosures. In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting (ASU 2016-09). ASU 2016-09 includes provisions intended to simplify various aspects related to accounting for and presentation of share-based payments in the financial statements. The areas for simplification include income tax consequences, forfeitures, classification of awards as either equity or liabilities and classification on the statement of cash flows. This ASU is effective for annual periods and interim periods within those annual periods beginning after December 15, 2016, and early adoption is permitted for financial statements that have not been previously issued. The Company early adopted the provisions of ASU 2016-09 during the quarter ended March 31, 2016. The cumulative effect adjustment from the modified retrospective transition of the income tax consequences, forfeitures and the classification of awards did not have a material effect on the Company’s financial statements or disclosures. Changes to the statement of cash flows have been applied prospectively beginning in the first quarter of 2016. See Note 9 - Employee Benefit and Stock Compensation Plans. In May 2014, the FASB issued ASU No. 2014-9 (ASU 2014-09), Revenue from Contracts with Customers. The core principle of ASU 2014-09 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also specifies the accounting for some costs to obtain or fulfill a contract with a customer, as well as enhanced disclosure requirements. In August 2015, the FASB issued ASU 2015-14 which deferred the effective date of ASU 2014-09 to fiscal years, and interim reporting periods within those fiscal years, beginning after December 15, 2017. In March 2016, the FASB issued ASU 2016-08 which clarified the revenue recognition implementation guidance on principal versus agent considerations and is effective during the same period as ASU 2014-09. In April 2016, the FASB issued ASU 2016-10 which clarified the revenue recognition guidance regarding the identification of performance obligations and the licensing implementation and is effective during the same period as ASU 2014-09. In May 2016, the FASB issued ASU 2016-12 which narrowly amended the revenue recognition guidance regarding collectability, noncash consideration, presentation of sales tax and transition. ASU 2016-12 is effective during the same period as ASU 2014-09. The Company is currently evaluating the effects of ASU 2014-09, ASU 2016-08, ASU 2016-10 and ASU 2016-12 on its financial statements and disclosures, if any. Preliminarily, the Company expects these ASUs to have more of an impact on the Fee-Based Lines segment than Commercial Banking segment, which generates the majority of the Company’s revenue. In June 2016, the FASB issued ASU 2016-13 is effective for annual periods and interim periods within those annual periods beginning after December 15, 2019, and early adoption is permitted for fiscal years, including interim periods, beginning after December 15, 2018. ASU 2016-13 will be applied through a cumulative effect adjustment to retained earnings (modified-retrospective approach), except for debt securities for which an other-than-temporary impairment had been recognized before the effective date. A prospective transition approach is required for these debt securities. While the Company is currently evaluating the effects of ASU 2016-13 on its financial statements and disclosures, the Company does expect ASU 2016-13 to add complexity and costs to its current credit loss evaluation process. In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments (ASU 2016-15), regarding how certain cash receipts and cash payments are presented and classified in the statements of cash flows. ASU 2016-15 addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice. The amendments of ASU 2016-13 are effective for public business entities for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years. Amendments in this ASU should be applied using a retrospective transition method to each period presented. The Company is evaluating the effects ASU 2016-15 will have on its financial statements and disclosures and does not expect these effects to be material.

Nature of Operations and Sign22

Nature of Operations and Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2016
Nature of Operations and Significant Accounting Policies
Schedule of Cash Flow, Supplemental Disclosures	Nine months ended September 30, (in thousands) 2016 2015 Cash paid during the period for: Interest $ $ Income taxes Other noncash activities: Available for sale securities transferred to held to maturity $ - $ Loans transferred to held for sale

Earnings per Common Share and23

Earnings per Common Share and Dividends Declared per Common Share (Tables)	9 Months Ended
	Sep. 30, 2016
Earnings per Common Share and Dividends Declared per Common Share
Schedule Of Weighted Average Shares Outstanding Used In Calculation Of Basic And Diluted Earnings Per Share	Three months ended Nine months ended September 30, September 30, (in thousands, except share and per share amounts) 2016 2015 2016 2015 Net income from continuing operations $ $ $ $ Net loss from discontinued operations - - - Net income Preferred stock dividends - - Net income available to common shareholders Dividends and undistributed earnings allocated to participating securities Earnings allocated to common shares (1) $ $ $ $ Weighted average common shares - issued Average unvested restricted share awards Weighted average common shares outstanding - basic Effect of dilutive stock options and awards outstanding Weighted average common shares outstanding - diluted Weighted average antidilutive securities outstanding (2) Basic earnings per common share $ $ $ $ Diluted earnings per common share $ $ $ $ Dividends declared per share $ $ $ $ (1) Earnings allocated to common shareholders for basic earnings per common share under the two-class method may differ from earnings allocated for diluted earnings per common share when use of the treasury method results in greater dilution than the two-class method. (2) Antidilutive shares excluded from the diluted earnings per common share computation.

Investments (Tables)

Investments (Tables)	9 Months Ended
	Sep. 30, 2016
Investments
Summary of amortized cost and estimated fair values of investment securities	At September 30, 2016 At December 31, 2015 Gross Gross Gross Gross Amortized unrealized unrealized Fair Amortized unrealized unrealized Fair (in thousands) cost gains losses value cost gains losses value Available for sale securities (AFS): Trust preferred securities $ $ $ $ $ $ $ $ Corporate debt securities Municipal securities - Total AFS $ $ $ $ $ $ $ $ Held to maturity securities (HTM): Mortgage-backed securities $ $ $ $ $ $ $ $ Trust preferred securities Municipal securities Total HTM $ $ $ $ $ $ $ $
Investments Classified By Contractual Maturity Date	Available for sale Held to maturity Amortized Fair Amortized Fair (in thousands) cost value cost value Due in one year or less $ $ $ - $ - Due after one year through five years Due after five years through ten years Due after ten years Mortgage-backed securities - - $ $ $ $
Schedule of Securities in an Unrealized Loss Position	September 30, 2016 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ $ $ $ $ $ Corporate debt securities - - Total AFS $ $ $ $ $ $ HTM Mortgage-backed securities $ $ $ $ $ $ Trust preferred securities Municipal securities - - Total HTM $ $ $ $ $ $ December 31, 2015 Less than 12 months 12 months or greater Total Fair Unrealized Fair Unrealized Fair Unrealized (in thousands) value loss value loss value loss AFS Trust preferred securities $ $ $ $ $ $ Corporate debt securities - - Municipal securities - - Total AFS $ $ $ $ $ $ HTM Mortgage-backed securities $ $ $ - $ - $ $ Trust preferred securities - - Municipal securities - - Total HTM $ $ $ $ $ $
Schedule Of Other Investments	September 30, December 31, (in thousands) 2016 2015 Bank stocks — at cost $ $ Investment in statutory trusts — equity method Total $ $

Loans (Tables)

Loans (Tables)	9 Months Ended
	Sep. 30, 2016
Loans
Schedule Of Loan Portfolio Segments	(in thousands) At September 30, 2016 At December 31, 2015 Commercial $ $ Real estate - mortgage Construction & land Consumer Other Loans held for investment Allowance for loan losses Unearned net loan fees Total net loans $ $
Schedule Of Major Portfolio Segment And Non Classified And Classified Loan Class	At September 30, 2016 (in thousands) Non-classified Classified Total Commercial Manufacturing $ $ $ Finance and insurance Healthcare Real estate services Construction Public administration Other Real estate - mortgage Residential & commercial owner-occupied Residential & commercial investor Construction & land - Consumer Other Total loans held for investment $ $ $ Unearned net loan fees Net loans held for investment $ At December 31, 2015 (in thousands) Non-classified Classified Total Commercial Manufacturing $ $ $ Finance and insurance Healthcare Real estate services Construction Public administration Other Real estate - mortgage Residential & commercial owner-occupied Residential & commercial investor Other - Construction & land Consumer Other Total loans held for investment $ $ $ Unearned net loan fees Net loans held for investment $
Schedule Of Allowance For Loan Losses	Three months ended September 30, Nine months ended September 30, (in thousands) 2016 2015 2016 2015 Allowance for loan losses, beginning of period Commercial $ $ $ $ Real estate - mortgage Construction & land Consumer Other Unallocated Total Provision Commercial $ $ $ $ Real estate - mortgage Construction & land Consumer Other Unallocated Total Charge-offs Commercial $ $ $ $ Real estate - mortgage - - Construction & land - - - Consumer - Other Total Recoveries Commercial $ $ $ $ Real estate - mortgage Construction & land Consumer Other - - - Total Allowance for loan losses, end of period Commercial $ $ $ $ Real estate - mortgage Construction & land Consumer Other Unallocated Total $ $ $ $
Schedule Of Loans Held For Investment And The Allowance For Loan And Credit Losses On The Basis Of Impairment Method	At September 30, 2016 At December 31, 2015 Individually evaluated for impairment Collectively evaluated for impairment Individually evaluated for impairment Collectively evaluated for impairment (in thousands) Loans Allowance Loans Allowance Loans Allowance Loans Allowance Commercial $ $ $ $ $ $ $ $ Real estate - mortgage Construction & land Consumer Other - - - - Unallocated - - - - - - Total $ $ $ $ $ $ $ $
Schedule Of Impaired Loans	At September 30, 2016 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans (1) allowance allowance allowance Commercial Manufacturing $ $ $ $ $ Finance and insurance - Healthcare - Real estate services - Construction Other Real estate - mortgage Residential & commercial owner-occupied Residential & commercial investor - Construction & land - Consumer Total $ $ $ $ $ At December 31, 2015 Recorded Recorded Recorded investment investment Unpaid investment with a with no principal in impaired related related Related (in thousands) balance loans (1) allowance allowance allowance Commercial Manufacturing $ $ $ $ - $ Finance and insurance - Healthcare - Real estate services - Construction - Other Real estate - mortgage Residential & commercial owner-occupied Residential & commercial investor - Construction & land Consumer Total $ $ $ $ $ (1) Recorded investment in impaired loans in this table may not agree to loans individually evaluated for impairment disclosed in the previous table due to certain loans being excluded pursuant to ASC 310-40-50-2. Interest income recognized on impaired loans presented in the table below primarily represents interest earned on troubled debt restructurings that meet the definition of an impaired loan pursuant to ASU 310-10-35-16 and are subject to disclosure requirement under ASU 310-10-50-15. Impaired loans Three months ended September 30, Nine months ended September 30, 2016 2015 2016 2015 (in thousands) Average recorded Interest income Average recorded Interest income Average recorded Interest income Average recorded Interest income Commercial Manufacturing $ $ $ $ $ $ $ $ Finance and insurance - - Healthcare - - - - Real estate services Construction Other Real estate - mortgage Residential & commercial owner-occupied - Residential & commercial investor Construction & land Consumer Other - - - - - - Total $ $ $ $ $ $ $ $
Schedule Of Transactions Related To Troubled Debt Restructurings	(in thousands) Performing Nonperforming Total Beginning balance at December 31, 2015 $ $ $ New restructurings Change in accrual status - Net paydowns Charge-offs - Ending balance at September 30, 2016 $ $ $
Schedule Of Troubled Debt Restructurings	Three months ended September 30, 2016 Three months ended September 30, 2015 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing - $ - $ - $ $ Construction Other Total $ $ $ $ Nine months ended September 30, 2016 Nine months ended September 30, 2015 Pre-modification Post-modification Pre-modification Post-modification outstanding outstanding outstanding outstanding Number of recorded recorded Number of recorded recorded ($ in thousands) contracts investment investment contracts investment investment Commercial Manufacturing $ $ $ $ Finance and insurance - - - Healthcare - - - Construction Other Real estate - mortgage Residential and commercial owner-occupied - - - Consumer Total $ $ $ $
Schedule Of Troubled Debt Restructurings That Subsequently Defaulted	Nine months ended September 30, 2016 2015 Troubled debt restructurings that subsequently defaulted Number of contracts Recorded investment Number of contracts Recorded investment Commercial Other $ - $ - Total $ - $ -
Schedule Of Nonaccrual Loans	(in thousands) At September 30, 2016 At December 31, 2015 Commercial Manufacturing $ $ Finance and insurance Real estate services - Construction Other Total commercial Residential & commercial owner-occupied Construction & land - Consumer Total nonaccrual loans $ $
Schedule Of Aging Of The Company's Loan Portfolio	At September 30, 2016 30 - 59 60 - 89 Days Days 90+ Days Total (in thousands) past due past due past due past due Current Total loans Commercial Manufacturing $ - $ - $ $ $ $ Finance and insurance - Healthcare - - Real estate services - - Construction - - - - Public administration - - - - Other - Real estate - mortgage Residential & commercial owner-occupied - - Residential & commercial investor - - - Construction & land - - - - Consumer - - Other - - - - Total loans held for investment $ $ $ $ $ $ Unearned net loan fees Net loans held for investment $ At December 31, 2015 Recorded investment in loans 30 - 59 60 - 89 90 days or more Days Days 90+ Days Total past due and (in thousands) past due past due past due past due Current Total loans accruing Commercial Manufacturing $ $ - $ - $ $ $ $ - Finance and insurance - - - - - Healthcare - - - Real estate services - - - Construction - - - - - Public administration - - - - - Other - - Real estate - mortgage Residential & commercial owner-occupied - - - Residential & commercial investor - - - - - Other - - - - - - - - Construction & land - - - Consumer - Other - - - - - Total loans held for investment $ $ $ $ $ $ $ Unearned net loan fees Net loans held for investment $

Accumulated Other Comprehensi26

Accumulated Other Comprehensive Income (Tables)	9 Months Ended
	Sep. 30, 2016
Accumulated Other Comprehensive Income
Schedule of reclassifications out of accumulated comprehensive income	Three months ended Nine months ended September 30, September 30, AOCI component (in thousands) 2016 2015 2016 2015 Line item in Condensed Consolidated Statements of Income Available for sale securities: Realized gain (loss) $ $ $ $ Net gain on securities, other assets and OREO Taxes Provision for income taxes Subtotal Held to maturity securities: Amortization of net unrealized gain on HTM securities Interest on taxable / nontaxable securities Taxes Provision for income taxes Subtotal Cash flow hedges: Loans Interest and fees on loans Debt Interest on subordinated debentures and notes payable Realized loss Taxes Provision for income taxes Subtotal Total reclassifications out of AOCI $ $ $ $
Schedule of beginning and ending balances of AOCI and changes during the period	Accumulated other comprehensive income (in thousands) Available for sale securities Held to maturity securities Cash flow hedges Total Balance at December 31, 2015 $ $ $ $ Other comprehensive income (loss) items - Reclassifications Other comprehensive loss, net of tax Balance at September 30, 2016 $ $ $ $

Derivatives (Tables)

Derivatives (Tables)	9 Months Ended
	Sep. 30, 2016
Derivatives
Schedule Of Derivative Instruments In The Statements Of Financial Position	Asset derivatives Liability derivatives Fair value at Fair value at Balance sheet September 30, December 31, Balance sheet September 30, December 31, (in thousands) classification 2016 2015 classification 2016 2015 Derivatives designated as hedging instruments under ASC 815: Cash flow hedge - interest rate swap Other assets $ - $ Accrued interest and other liabilities $ $ Fair value hedge - interest rate swap Other assets $ - $ Accrued interest and other liabilities $ $ Derivatives not designated as hedging instruments under ASC 815: Interest rate swap Other assets $ $ Accrued interest and other liabilities $ $ Foreign exchange forward contracts Other assets $ $ Accrued interest and other liabilities $ $
Schedule Of Fair Value Of Derivative Financial Instruments And Their Classification On Condensed Consolidated Balance Sheets	At September 30, 2016 Assets Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives not designated as hedges (1) $ $ - $ $ $ - $ Total $ $ - $ $ $ - $ At September 30, 2016 Liabilities Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ $ - $ $ - $ $ - Derivatives not designated as hedges (2) - Securities sold under agreements to repurchase (3) - - - Total $ $ - $ $ $ $ At December 31, 2015 Assets Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (1) $ $ - $ $ $ - $ Derivatives not designated as hedges (1) - - Total $ $ - $ $ $ - $ At December 31, 2015 Liabilities Gross amounts not offset Gross Gross Financial Net (in thousands) amounts amounts offset Net amounts Instruments Collateral Amount Derivatives designated as hedges (2) $ $ - $ $ $ $ - Derivatives not designated as hedges (2) - Securities sold under agreements to repurchase (3) - - - Total $ $ - $ $ $ $ (1) Included in other assets. (2) Included in accrued interest and other liabilities. (3) Separately stated in the Condensed Consolidated Balance Sheets.
Schedule Of Notional Amounts Of Outstanding Derivative Positions	(in thousands) Notional Fixed rate Termination date Hedged item - Junior subordinated debentures issued by: CoBiz Statutory Trust I $ % March 17, 2022 CoBiz Capital Trust II $ % April 23, 2020 CoBiz Capital Trust III $ % March 30, 2024

Borrowed Funds (Tables)

Borrowed Funds (Tables)	9 Months Ended
	Sep. 30, 2016
Borrowed Funds
Schedule of short-term borrowings	September 30, December 31, (in thousands) 2016 2015 Securities sold under agreements to repurchase (secured by pledge of principally mortgage-backed securities with an estimated fair value of $53,156 and $49,882, respectively) $ $

Employee Benefit and Stock Co29

Employee Benefit and Stock Compensation Plans (Tables)	9 Months Ended
	Sep. 30, 2016
Employee Benefit and Stock Compensation Plans
Summary Of Changes In Option Awards	Weighted average Shares exercise price Outstanding at December 31, 2015 $ Granted Exercised Forfeited Outstanding at September 30, 2016 $ Exercisable at September 30, 2016 $
Summary Of Changes In Stock Awards	Weighted average Shares grant date fair value Unvested at December 31, 2015 $ Granted Vested Forfeited Unvested at September 30, 2016 $

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2016
Leases
Leases	(in thousands) At September 30, 2016 2016 (remainder) $ 2017 2018 2019 2020 Thereafter Total $

Segments (Tables)

Segments (Tables)	9 Months Ended
	Sep. 30, 2016
Segments
Summary Of Results Of Operations By Operating Segment	Three months ended September 30, 2016 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ $ - $ $ Total interest expense Provision for loan losses - Noninterest income Noninterest expense Management fees and allocations, net of tax - Provision (benefit) for income taxes Net income (loss) $ $ $ $ Nine months ended September 30, 2016 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ $ $ $ Total interest expense Provision for loan losses - Noninterest income Noninterest expense Management fees and allocations, net of tax - Provision (benefit) for income taxes Net income (loss) $ $ $ $ Three months ended September 30, 2015 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ $ $ $ Total interest expense Provision for loan losses - Noninterest income Noninterest expense Management fees and allocations, net of tax - Provision (benefit) for income taxes Net income (loss) $ $ $ $ Nine months ended September 30, 2015 Corporate Income Statement Commercial Fee-Based Support and (in thousands) Banking Lines Other Consolidated Total interest income $ $ $ $ Total interest expense Provision for loan losses - Noninterest income Noninterest expense Management fees and allocations, net of tax - Provision (benefit) for income taxes Net income (loss) from continuing operations $ $ $ $ Net loss from discontinued operations - - Net income (loss) $ $ $ $

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
	Sep. 30, 2016
Fair Value Measurements
Financial Assets And Liabilities Measured At Fair Value On Recurring Basis	Fair value measurements using: Quoted prices in Significant other Significant other active markets for observable observable Balance at identical assets inputs inputs (in thousands) September 30, 2016 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ $ $ $ Corporate debt securities - - Municipal securities - - Total available for sale securities $ $ $ $ Derivatives: Fair value hedges $ - $ - $ - $ - Non-designated hedges - - Foreign exchange forward contracts - - Total derivative assets $ $ - $ $ - Liabilities Derivatives: Cash flow hedges $ $ - $ $ - Fair value hedges - - Non-designated hedges - - Foreign exchange forward contracts - - Total derivative liabilities $ $ - $ $ - Fair value measurements using: Quoted prices in Significant other Significant other active markets for observable observable Balance at identical assets inputs inputs (in thousands) December 31, 2015 (Level 1) (Level 2) (Level 3) Assets Available for sale securities: Trust preferred securities $ $ $ $ Corporate debt securities - - Municipal securities - - Total available for sale securities $ $ $ $ Derivatives: Cash flow hedges $ $ - $ $ - Fair value hedges - - Non-designated hedges - - Foreign exchange forward contracts - - Total derivative assets $ $ - $ $ - Liabilities Derivatives: Cash flow hedges $ $ - $ $ - Fair value hedge - - Non-designated hedges - - Foreign exchange forward contracts - - Total derivative liabilities $ $ - $ $ -
Reconciliation Of Financial Assets Measured At Fair Value On Recurring Basis Using Significant Unobservable Inputs	Three months ended Nine months ended September 30, September 30, (in thousands) 2016 2015 2016 2015 Beginning balance $ $ $ $ Transfers - - - Net accretion Sales / calls / maturities - - - Unrealized gain included in comprehensive income Ending balance $ $ $ $
Schedule Of Assets Measured At Fair Value On A Nonrecurring Basis	Fair value measurements using: Quoted prices in Significant other Significant other active markets for observable observable identical assets inputs inputs (in thousands) Total (Level 1) (Level 2) (Level 3) At September 30, 2016 Impaired loans $ $ - $ - $ OREO $ $ - $ - $ At December 31, 2015 Impaired loans $ $ - $ - $ OREO $ $ - $ - $
Schedule of Gains And Losses Recorded In Relation To Assets And Liabilities Measured On Nonrecurring Basis	Gain for the three months ended Gain for the nine months ended September 30, September 30, (in thousands) 2016 2015 2016 2015 Impaired loans $ $ $ $ OREO $ - $ $ - $
Reconciliation Of Other Real Estate Owned Fair Value Measurement	At At (in thousands) September 30, 2016 December 31, 2015 OREO recorded at fair value $ $ Estimated selling costs OREO $ $
Summary Of Other Real Estate Owned Transactions	Below is a summary of OREO transactions for the nine months ended September 30, 2016: (in thousands) OREO Beginning OREO balance $ OREO sales - Valuation adjustments - Ending OREO balance $
Fair Value Measurements, Recurring And Nonrecurring, Valuation Techniques	At September 30, 2016 Fair Value Weighted Category (in thousands) Valuation Technique Unobservable Input Average Range Trust preferred securities $ Market approach Discount to carrying value using broker quotes or observable prices on similar securities 14 % 1% to 20% Impaired loans: Commercial $ Sales comparison (1) Management discount for asset type 33 % 0% - 76% Commercial Sales comparison (2) Sales comparison adjustments (38) % NA Real estate - mortgage Sales comparison (2) Sales comparison adjustments 16 % 9% - 18% Consumer Sales comparison (2) Sales comparison adjustments 10 % NA Total impaired loans $ OREO: Commercial $ Property appraisals (2) Management discount for property type and recent market volatility 0 % NA Construction & land Property appraisals (2) Management discount for property type and recent market volatility 17 % NA Total OREO $ At December 31, 2015 Fair Value Weighted Category (in thousands) Valuation Technique Unobservable Input Average Range Trust preferred securities $ Market approach Discount to carrying value using broker quotes or observable prices on similar securities 15 % 1% to 18% Impaired loans: Commercial $ Sales comparison (1) Management discount for asset type 47 % 0% to 81% Commercial Sales comparison (2) Sales comparison adjustments (32) % NA Real estate - mortgage Sales comparison (2) Sales comparison adjustments 12 % (15)% to 17% Construction & land Sales comparison (2) Sales comparison adjustments (24) % NA Consumer Sales comparison (2) Sales comparison adjustments 11 % (2)% to 14% Total impaired loans $ OREO: Commercial $ Property appraisals (2) Management discount for property type and recent market volatility 0 % 0% Construction & land Property appraisals (2) Management discount for property type and recent market volatility 17 % NA Total OREO $ (1) Discount represents management’s discounts applied to market valuation of various business asset types including accounts receivable and other commercial assets. (2) The fair value of OREO and collateral-dependent impaired loans is based on third-party property appraisals. The majority of the appraisals utilize a single valuation approach or a combination of approaches including a market approach, where prices and other relevant information generated by market transactions involving identical or comparable properties are used to determine fair value. Appraisals may include an ‘as is’ sales comparison approach and an ‘upon completion’ valuation approach. Adjustments are routinely made in the appraisal process by third-party appraisers to adjust for differences between the comparable sales and income data. Adjustments also result from the consideration of relevant economic and demographic factors with the potential to affect property values. Also, prospective values are based on the market conditions which exist at the date of inspection combined with informed forecasts based on current trends in supply and demand for the property types under appraisal. For sales comparisons, positive adjustments disclosed in these tables represent increases and negative adjustments represent decreases in fair value.
Schedule Of Estimated Fair Value Of Financial Instruments	September 30, 2016 December 31, 2015 Carrying Estimated Carrying Estimated (in thousands) value fair value value fair value Financial assets: Cash and cash equivalents $ $ $ $ Investment securities available for sale Investment securities held to maturity Other investments Loans — net Accrued interest receivable Derivatives Financial liabilities: Deposits $ $ $ $ Securities sold under agreements to repurchase Other short-term borrowings Accrued interest payable Subordinated notes payable Junior subordinated debentures Derivatives

Regulatory Matters (Tables)

Regulatory Matters (Tables)	9 Months Ended
	Sep. 30, 2016
Regulatory Matters
Schedule Of Regulatory Capital Ratios Of The Company And The Bank	At September 30, 2016 Capitalized Ratio Bank Company Minimum ratio (in thousands) Ratios Ratios Well (1) plus fully phased-in CCB Common equity tier 1 capital % % % % Tier 1 capital % % % % Total capital % % % % Tier 1 leverage % % % % (1) The ratios for the well-capitalized requirement are only applicable to the Bank. However, the Company manages its capital position as if the requirement applies to the consolidated entity and has presented the ratios as if they also applied to the Company.

Supplemental Financial Data (Ta

Supplemental Financial Data (Tables)	9 Months Ended
	Sep. 30, 2016
Supplemental Financial Data
Schedule Of Other Income And Other Expense	Three months ended Nine months ended Other noninterest income September 30, September 30, (in thousands) 2016 2015 2016 2015 Loan fees $ $ $ $ Other customer service fees Bank-owned life insurance Equity method investments Interest rate swaps - Other Total $ $ $ $ Three months ended Nine months ended Other noninterest expense September 30, September 30, (in thousands) 2016 2015 2016 2015 Marketing and business development $ $ $ $ Service contracts Professional fees Office supplies and delivery Other Total $ $ $ $

Nature of Operations and Sign35

Nature of Operations and Significant Accounting Policies - Organization (Details)	9 Months Ended
	Sep. 30, 2016location
Denver, Colorado
Organization
Number of branches	9
Boulder, Colorado
Organization
Number of branches	1
Vail, Colorado
Organization
Number of branches	1
Colorado Springs, Colorado
Organization
Number of branches	1
Fort Collins, Colorado
Organization
Number of branches	1
Phoenix, Arizona
Organization
Number of branches	4

Nature of Operations and Sign36

Nature of Operations and Significant Accounting Policies - Cash and Cash Equivalents (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Supplemental disclosure of certain cash and cash equivalents
Interest	$ 8,141	$ 5,609
Income taxes	5,538	6,953
Available for sale securities transferred to held to maturity		288,598
Loans transferred to held for sale	$ 60	$ 1,628
Impaired loans
Impaired Loans, Threshold for payment shortfall to be considered for impairment, percentage of contractual payment	10.00%
Investments
Trading Securities	$ 0		$ 0

Earnings per Common Share and37

Earnings per Common Share and Dividends Declared per Common Share - Schedule of Weighted Average Shares Outstanding Used in Calculation of Basic and Diluted Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Earnings per Common Share and Dividends Declared per Common Share
Net income from continuing operations	$ 10,269	$ 6,954	$ 26,166	$ 21,740
Net income (loss) from discontinued operations				(71)
NET INCOME	10,269	6,954	26,166	21,669
Preferred stock dividends		(33)		(320)
Net income available to common shareholders	10,269	6,921	26,166	21,349
Dividends and undistributed earnings allocated to participating securities	(116)	(84)	(300)	(279)
Earnings allocated to common shares	$ 10,153	$ 6,837	$ 25,866	$ 21,070
Weighted average common shares - issued	41,434,195	41,041,238	41,334,632	40,958,467
Average unvested restricted share awards	(462,927)	(498,049)	(472,885)	(530,220)
Weighted average common shares outstanding - basic	40,971,268	40,543,189	40,861,747	40,428,247
Effect of dilutive stock options and awards outstanding	220,779	280,984	180,676	246,649
Weighted average common shares outstanding - diluted	41,192,047	40,824,173	41,042,423	40,674,896
Weighted average antidilutive securities outstanding	118,596	92,859	158,154	182,627
Basic earnings per common share	$ 0.25	$ 0.17	$ 0.63	$ 0.52
Diluted earnings per common share	0.25	0.17	0.63	0.52
Dividends declared per share	$ 0.050	$ 0.045	$ 0.140	$ 0.125

Investments - Reconciliation fr

Investments - Reconciliation from Amortized Cost to Fair Value of Investment Securities (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Available for sale securities (AFS):
Amortized cost	$ 136,402	$ 150,905
Gross unrealized gains	4,418	3,415
Gross unrealized losses	537	635
Fair value	140,283	153,685
Held to maturity securities (HTM):
Amortized cost	307,639	346,666
Gross unrealized gains	2,206	1,066
Gross unrealized losses	847	2,156
Fair value	308,998	345,576
Mortgage-backed securities
Held to maturity securities (HTM):
Amortized cost	273,430	312,658
Gross unrealized gains	1,281	99
Gross unrealized losses	646	2,059
Fair value	274,065	310,698
Trust preferred securities
Available for sale securities (AFS):
Amortized cost	36,398	44,845
Gross unrealized gains	1,666	1,684
Gross unrealized losses	535	446
Fair value	37,529	46,083
Held to maturity securities (HTM):
Amortized cost	10,596	10,524
Gross unrealized gains	500	816
Gross unrealized losses	198	85
Fair value	10,898	11,255
Corporate debt securities
Available for sale securities (AFS):
Amortized cost	96,735	102,273
Gross unrealized gains	2,645	1,632
Gross unrealized losses	2	169
Fair value	99,378	103,736
Municipal securities
Available for sale securities (AFS):
Amortized cost	3,269	3,787
Gross unrealized gains	107	99
Gross unrealized losses		20
Fair value	3,376	3,866
Held to maturity securities (HTM):
Amortized cost	23,613	23,484
Gross unrealized gains	425	151
Gross unrealized losses	3	12
Fair value	$ 24,035	$ 23,623

Investments - Schedule of Amort

Investments - Schedule of Amortized Cost and Estimated Fair Value of Investment Securities by Contractual Maturities (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Available-for-sale, Amortized cost
Available for sale securities, Amortized cost, Due in one year or less	$ 40,981
Available for sale securities, Amortized cost, Due after one year through five years	40,248
Available for sale securities, Amortized cost, Due after five years through ten years	18,774
Available for sale securities, Amortized cost, Due after ten years	36,399
Available for sale securities, Amortized cost, Amortized cost	136,402
Available-for-sale, Fair value
Available for sale securities, Estimated fair value, Due in one year or less	41,232
Available for sale securities, Estimated fair value, Due after one year through five years	41,471
Available for sale securities, Estimated fair value, Due after five years through ten years	20,051
Available for sale securities, Estimated fair value, Due after ten years	37,529
Fair value	140,283	$ 153,685
Held-to-maturity, Amortized cost
Held to maturity securities, Amortized cost, Due after one year through five years	19,970
Held to maturity securities, Amortized cost, Due after five years through ten years	3,086
Held to maturity securities, Amortized cost, Due after ten years	11,153
Held to maturity securities, Amortized cost, Mortgage-backed securities	273,430
Held-to-maturity Securities, Total	307,639	346,666
Held-to-maturity, Fair value
Held to maturity securities, Estimated fair value, Due after one year through five years	20,323
Held to maturity securities, Estimated fair value, Due after five years through ten years	3,152
Held to maturity securities, Estimated fair value, Due after ten years	11,458
Held to maturity securities, Estimated fair value, Mortgage-backed securities	274,065
Fair value	$ 308,998	$ 345,576

Investments - Narrative (Detail

Investments - Narrative (Details) - USD ($) $ in Millions	Sep. 30, 2016	Dec. 31, 2015
Investments
Investment securities pledged to secure public deposits	$ 145	$ 157.3
Public deposits	$ 116.2	$ 113.6

Investments - Schedule of Secur

Investments - Schedule of Securities Related to Unrecognized OTTI (Details) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2016USD ($)security	Dec. 31, 2015USD ($)security
Securities in Continuous Unrealized Loss Positions
Number of credit-impaired securities | security	0	0
Securities in unrealized loss position | security	115	168
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	$ 16,893	$ 49,316
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	8,250	995
Available for sale securities in continuous unrealized loss position, Fair Value	25,143	50,311
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	220	628
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	317	7
Available for sale securities in continuous unrealized loss position, Unrealized loss	537	635
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	45,548	284,151
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	51,966	780
HTM securities in continuous unrealized loss position, Fair Value, Total	97,514	284,931
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	251	2,071
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	596	85
HTM securities in continuous unrealized loss position, Unrealized loss, Total	847	2,156
Mortgage-backed securities
Securities in Continuous Unrealized Loss Positions
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	40,295	281,547
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	51,206
HTM securities in continuous unrealized loss position, Fair Value, Total	91,501	281,547
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	161	2,059
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	485
HTM securities in continuous unrealized loss position, Unrealized loss, Total	646	2,059
Trust preferred securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	11,896	15,294
Available for sale securities in continuous unrealized loss position, Fair Value, 12 months or greater	8,250	995
Available for sale securities in continuous unrealized loss position, Fair Value	20,146	16,289
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	218	439
Available for sale securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	317	7
Available for sale securities in continuous unrealized loss position, Unrealized loss	535	446
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	4,175
HTM securities in continuous unrealized loss position, Fair value, 12 months or greater	760	780
HTM securities in continuous unrealized loss position, Fair Value, Total	4,935	780
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	87
HTM securities in continuous unrealized loss position, Unrealized loss, 12 months or greater	111	85
HTM securities in continuous unrealized loss position, Unrealized loss, Total	198	85
Corporate debt securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months	4,997	33,591
Available for sale securities in continuous unrealized loss position, Fair Value	4,997	33,591
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	2	169
Available for sale securities in continuous unrealized loss position, Unrealized loss	2	169
Municipal securities
Securities in Continuous Unrealized Loss Positions
Available for sale securities in continuous unrealized loss position, Fair Value, Less than 12 months		431
Available for sale securities in continuous unrealized loss position, Fair Value		431
Available for sale securities in continuous unrealized loss position, Unrealized loss, Less than 12 months		20
Available for sale securities in continuous unrealized loss position, Unrealized loss		20
HTM securities in continuous unrealized loss position, Fair Value, Less than 12 months	1,078	2,604
HTM securities in continuous unrealized loss position, Fair Value, Total	1,078	2,604
HTM securities in continuous unrealized loss position, Unrealized loss, Less than 12 months	3	12
HTM securities in continuous unrealized loss position, Unrealized loss, Total	$ 3	$ 12

Investments - Schedule of Other

Investments - Schedule of Other Investments (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Investments
Bank stocks - at cost	$ 4,988	$ 10,289
Investment in statutory trusts - equity method	2,172	2,172
Total	$ 7,160	$ 12,461

Loans - Schedule of Loan Portfo

Loans - Schedule of Loan Portfolio Segments (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Jun. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014
Loan portfolio segments
Loans held for investment	$ 2,827,511		$ 2,699,509
Allowance for loan losses	(33,529)	$ (34,344)	(40,686)	$ (34,899)	$ (33,832)	$ (32,765)
Unearned net loan fees	(406)		(304)
Total net loans	2,793,576		2,658,519
Commercial
Loan portfolio segments
Loans held for investment	1,195,177		1,174,570
Allowance for loan losses	(16,335)	(17,349)	(24,215)	(18,534)	(17,568)	(14,614)
Real estate - mortgage
Loan portfolio segments
Loans held for investment	1,099,470		1,017,072
Allowance for loan losses	(10,537)	(10,281)	(10,372)	(9,742)	(10,879)	(12,463)
Construction and land
Loan portfolio segments
Loans held for investment	171,686		202,011
Allowance for loan losses	(2,186)	(2,335)	(2,111)	(2,510)	(2,206)	(2,316)
Consumer
Loan portfolio segments
Loans held for investment	263,813		253,240
Allowance for loan losses	(2,783)	(2,660)	(2,592)	(2,593)	(2,201)	(2,329)
Other
Loan portfolio segments
Loans held for investment	97,365		52,616
Allowance for loan losses	$ (901)	$ (786)	$ (643)	$ (687)	$ (609)	$ (488)

Loans (Narrative) (Details)

Loans (Narrative) (Details) $ in Millions	Sep. 30, 2016USD ($)
Loans
Loans collateralized under FHLB advancement agreement	$ 838
Lending value of loans collateralized under FHLB advancement agreement	$ 581.8

Loans - Schedule of Major Portf

Loans - Schedule of Major Portfolio Segment and Non-Classified and Classified Loan Class (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Loan portfolio segments
Loans held for investment	$ 2,827,511	$ 2,699,509
Unearned net loan fees	(406)	(304)
Total loans	2,827,105	2,699,205
Non-classified
Loan portfolio segments
Loans held for investment	2,769,135	2,648,431
Classified
Loan portfolio segments
Loans held for investment	58,376	51,078
Commercial
Loan portfolio segments
Loans held for investment	1,195,177	1,174,570
Commercial | Non-classified
Loan portfolio segments
Loans held for investment	1,149,355	1,132,845
Commercial | Classified
Loan portfolio segments
Loans held for investment	45,822	41,725
Commercial | Manufacturing
Loan portfolio segments
Loans held for investment	116,735	135,050
Commercial | Manufacturing | Non-classified
Loan portfolio segments
Loans held for investment	113,909	132,083
Commercial | Manufacturing | Classified
Loan portfolio segments
Loans held for investment	2,826	2,967
Commercial | Finance and insurance
Loan portfolio segments
Loans held for investment	60,091	64,279
Commercial | Finance and insurance | Non-classified
Loan portfolio segments
Loans held for investment	59,608	64,243
Commercial | Finance and insurance | Classified
Loan portfolio segments
Loans held for investment	483	36
Commercial | Health care
Loan portfolio segments
Loans held for investment	135,615	126,511
Commercial | Health care | Non-classified
Loan portfolio segments
Loans held for investment	135,227	126,049
Commercial | Health care | Classified
Loan portfolio segments
Loans held for investment	388	462
Commercial | Real estate services
Loan portfolio segments
Loans held for investment	124,153	118,863
Commercial | Real estate services | Non-classified
Loan portfolio segments
Loans held for investment	123,206	117,283
Commercial | Real estate services | Classified
Loan portfolio segments
Loans held for investment	947	1,580
Commercial | Construction
Loan portfolio segments
Loans held for investment	68,911	57,906
Commercial | Construction | Non-classified
Loan portfolio segments
Loans held for investment	64,268	56,581
Commercial | Construction | Classified
Loan portfolio segments
Loans held for investment	4,643	1,325
Commercial | Wholesale and retail trade
Loan portfolio segments
Loans held for investment	247,115	221,112
Commercial | Wholesale and retail trade | Non-classified
Loan portfolio segments
Loans held for investment	245,922	211,373
Commercial | Wholesale and retail trade | Classified
Loan portfolio segments
Loans held for investment	1,193	9,739
Commercial | Commercial - Other
Loan portfolio segments
Loans held for investment	442,557	450,849
Commercial | Commercial - Other | Non-classified
Loan portfolio segments
Loans held for investment	407,215	425,233
Commercial | Commercial - Other | Classified
Loan portfolio segments
Loans held for investment	35,342	25,616
Real estate - mortgage
Loan portfolio segments
Loans held for investment	1,099,470	1,017,072
Real estate - mortgage | Residential and commercial owner-occupied
Loan portfolio segments
Loans held for investment	473,706	436,855
Real estate - mortgage | Residential and commercial investor
Loan portfolio segments
Loans held for investment	625,764	578,892
Real estate - mortgage | Real estate - mortgage - Other
Loan portfolio segments
Loans held for investment		1,325
Real estate - mortgage | Non-classified
Loan portfolio segments
Loans held for investment	1,090,426	1,010,965
Real estate - mortgage | Non-classified | Residential and commercial owner-occupied
Loan portfolio segments
Loans held for investment	466,452	431,805
Real estate - mortgage | Non-classified | Residential and commercial investor
Loan portfolio segments
Loans held for investment	623,974	577,835
Real estate - mortgage | Non-classified | Real estate - mortgage - Other
Loan portfolio segments
Loans held for investment		1,325
Real estate - mortgage | Classified
Loan portfolio segments
Loans held for investment	9,044	6,107
Real estate - mortgage | Classified | Residential and commercial owner-occupied
Loan portfolio segments
Loans held for investment	7,254	5,050
Real estate - mortgage | Classified | Residential and commercial investor
Loan portfolio segments
Loans held for investment	1,790	1,057
Construction and land
Loan portfolio segments
Loans held for investment	171,686	202,011
Construction and land | Non-classified
Loan portfolio segments
Loans held for investment	171,686	201,984
Construction and land | Classified
Loan portfolio segments
Loans held for investment		27
Consumer
Loan portfolio segments
Loans held for investment	263,813	253,240
Consumer | Non-classified
Loan portfolio segments
Loans held for investment	262,123	252,869
Consumer | Classified
Loan portfolio segments
Loans held for investment	1,690	371
Other
Loan portfolio segments
Loans held for investment	97,365	52,616
Other | Non-classified
Loan portfolio segments
Loans held for investment	95,545	49,768
Other | Classified
Loan portfolio segments
Loans held for investment	$ 1,820	$ 2,848

Loans - Schedule of Allowance f

Loans - Schedule of Allowance for Loan Losses (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Allowance for loan losses
Allowance for loan losses, beginning of period	$ 34,344	$ 33,832	$ 40,686	$ 32,765
Provision	(1,168)	762	(2,450)	1,030
Charge-offs	(231)	(87)	(6,654)	(1,121)
Net recoveries of impaired loans	584	392	1,947	2,225
Allowance for loan losses, end of period	33,529	34,899	33,529	34,899
Commercial
Allowance for loan losses
Allowance for loan losses, beginning of period	17,349	17,568	24,215	14,614
Provision	(1,247)	944	(2,306)	4,242
Charge-offs	(227)	(32)	(6,630)	(501)
Net recoveries of impaired loans	460	54	1,056	179
Allowance for loan losses, end of period	16,335	18,534	16,335	18,534
Real estate - mortgage
Allowance for loan losses
Allowance for loan losses, beginning of period	10,281	10,879	10,372	12,463
Provision	247	(1,104)	138	(3,641)
Charge-offs		(38)		(186)
Net recoveries of impaired loans	9	5	27	1,106
Allowance for loan losses, end of period	10,537	9,742	10,537	9,742
Construction and land
Allowance for loan losses
Allowance for loan losses, beginning of period	2,335	2,206	2,111	2,316
Provision	(250)	(19)	(765)	(360)
Charge-offs				(104)
Net recoveries of impaired loans	101	323	840	658
Allowance for loan losses, end of period	2,186	2,510	2,186	2,510
Consumer
Allowance for loan losses
Allowance for loan losses, beginning of period	2,660	2,201	2,592	2,329
Provision	109	396	187	299
Charge-offs		(14)	(20)	(45)
Net recoveries of impaired loans	14	10	24	10
Allowance for loan losses, end of period	2,783	2,593	2,783	2,593
Other
Allowance for loan losses
Allowance for loan losses, beginning of period	786	609	643	488
Provision	119	81	262	212
Charge-offs	(4)	(3)	(4)	(285)
Net recoveries of impaired loans				272
Allowance for loan losses, end of period	901	687	901	687
Unallocated
Allowance for loan losses
Allowance for loan losses, beginning of period	933	369	753	555
Provision	(146)	464	34	278
Allowance for loan losses, end of period	$ 787	$ 833	$ 787	$ 833

Loans - Schedule of Loans Held

Loans - Schedule of Loans Held for Investment and Allowance for Loan Losses and Credit Losses (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	$ 30,337	$ 43,913
Allowance for loan losses, Individually evaluated for impairment	3,976	11,543
Loans held for investment, Collectively evaluated for impairment	2,796,768	2,655,292
Allowance for loan losses, Collectively evaluated for impairment	29,553	29,143
Commercial
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	24,105	33,927
Allowance for loan losses, Individually evaluated for impairment	3,598	10,975
Loans held for investment, Collectively evaluated for impairment	1,171,983	1,141,452
Allowance for loan losses, Collectively evaluated for impairment	12,737	13,240
Real estate - mortgage
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	4,034	6,521
Allowance for loan losses, Individually evaluated for impairment	156	320
Loans held for investment, Collectively evaluated for impairment	1,094,949	1,009,747
Allowance for loan losses, Collectively evaluated for impairment	10,381	10,052
Construction and land
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	1,960	2,610
Allowance for loan losses, Individually evaluated for impairment	112	192
Loans held for investment, Collectively evaluated for impairment	168,634	198,671
Allowance for loan losses, Collectively evaluated for impairment	2,074	1,919
Consumer
Allowance for loan losses
Loans held for investment, Individually evaluated for impairment	238	855
Allowance for loan losses, Individually evaluated for impairment	110	56
Loans held for investment, Collectively evaluated for impairment	263,633	252,462
Allowance for loan losses, Collectively evaluated for impairment	2,673	2,536
Other
Allowance for loan losses
Loans held for investment, Collectively evaluated for impairment	97,569	52,960
Allowance for loan losses, Collectively evaluated for impairment	901	643
Unallocated
Allowance for loan losses
Allowance for loan losses, Collectively evaluated for impairment	$ 787	$ 753

Loans - Schedule of Impaired Lo

Loans - Schedule of Impaired Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Impaired receivables with and without related allowance
Unpaid principal balance	$ 30,832	$ 45,573
Recorded investment on impaired loans	30,337	43,913
Recorded investment with a related allowance	29,560	43,458
Recorded investment with no related allowance	777	455
Related allowance	3,976	11,543
Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	24,600	35,554
Recorded investment on impaired loans	24,105	33,927
Recorded investment with a related allowance	23,793	33,919
Recorded investment with no related allowance	312	8
Related allowance	3,598	10,975
Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	4,034	6,521
Recorded investment on impaired loans	4,034	6,521
Recorded investment with a related allowance	3,593	6,210
Recorded investment with no related allowance	441	311
Related allowance	156	320
Construction and land
Impaired receivables with and without related allowance
Unpaid principal balance	1,960	2,643
Recorded investment on impaired loans	1,960	2,610
Recorded investment with a related allowance	1,960	2,583
Recorded investment with no related allowance		27
Related allowance	112	192
Consumer
Impaired receivables with and without related allowance
Unpaid principal balance	238	855
Recorded investment on impaired loans	238	855
Recorded investment with a related allowance	214	746
Recorded investment with no related allowance	24	109
Related allowance	110	56
Manufacturing | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	3,118	5,002
Recorded investment on impaired loans	3,095	4,795
Recorded investment with a related allowance	3,092	4,795
Recorded investment with no related allowance	3
Related allowance	247	476
Finance and insurance | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	27	36
Recorded investment on impaired loans	27	36
Recorded investment with a related allowance	27	36
Related allowance	27	36
Health care
Impaired receivables with and without related allowance
Unpaid principal balance	201
Recorded investment on impaired loans	201
Recorded investment with a related allowance	201
Related allowance	11
Health care | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance		125
Recorded investment on impaired loans		125
Recorded investment with a related allowance		125
Related allowance		9
Real estate services | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	7,012	7,638
Recorded investment on impaired loans	7,012	7,638
Recorded investment with a related allowance	7,012	7,638
Related allowance	399	559
Construction | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	2,792	1,906
Recorded investment on impaired loans	2,755	1,874
Recorded investment with a related allowance	2,473	1,874
Recorded investment with no related allowance	282
Related allowance	182	309
Commercial - Other | Commercial
Impaired receivables with and without related allowance
Unpaid principal balance	11,450	20,847
Recorded investment on impaired loans	11,015	19,459
Recorded investment with a related allowance	10,988	19,451
Recorded investment with no related allowance	27	8
Related allowance	2,732	9,586
Residential and commercial owner-occupied | Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	1,646	1,790
Recorded investment on impaired loans	1,646	1,790
Recorded investment with a related allowance	1,205	1,479
Recorded investment with no related allowance	441	311
Related allowance	69	185
Residential and commercial investor | Real estate - mortgage
Impaired receivables with and without related allowance
Unpaid principal balance	2,388	4,731
Recorded investment on impaired loans	2,388	4,731
Recorded investment with a related allowance	2,388	4,731
Related allowance	$ 87	$ 135

Loans - Schedule of Impaired 49

Loans - Schedule of Impaired Loans (Average Recorded Investment in Impaired Loans and Interest Income Recognized) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Impaired Loans: Average recorded investment and interest income
Average recorded investment	$ 31,348	$ 34,293	$ 34,857	$ 33,659
Interest income recognized	407	453	1,086	1,486
Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment	23,975	23,979	25,835	21,985
Interest income recognized	321	335	842	939
Real estate - mortgage
Impaired Loans: Average recorded investment and interest income
Average recorded investment	4,821	6,339	6,048	6,655
Interest income recognized	48	35	150	241
Construction and land
Impaired Loans: Average recorded investment and interest income
Average recorded investment	2,309	2,677	2,470	3,036
Interest income recognized	34	23	76	83
Consumer
Impaired Loans: Average recorded investment and interest income
Average recorded investment	243	1,298	504	1,948
Interest income recognized	4	60	18	212
Other
Impaired Loans: Average recorded investment and interest income
Average recorded investment				35
Interest income recognized				11
Manufacturing | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment	3,100	5,967	3,815	5,915
Interest income recognized	31	72	122	252
Finance and insurance | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment	28	108	31	196
Interest income recognized		13		21
Health care | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment	205		194
Interest income recognized	3		9
Real estate services | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment	7,046	7,894	7,240	8,117
Interest income recognized	78	70	206	215
Construction | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment	1,998	1,791	1,694	1,604
Interest income recognized	59	37	98	84
Commercial - Other | Commercial
Impaired Loans: Average recorded investment and interest income
Average recorded investment	11,598	8,219	12,861	6,153
Interest income recognized	150	143	407	367
Residential and commercial owner-occupied | Real estate - mortgage
Impaired Loans: Average recorded investment and interest income
Average recorded investment	1,680	1,555	1,877	1,431
Interest income recognized	18		43	103
Residential and commercial investor | Real estate - mortgage
Impaired Loans: Average recorded investment and interest income
Average recorded investment	3,141	4,784	4,171	5,224
Interest income recognized	$ 30	$ 35	$ 107	$ 138

Loans - Schedule of Transaction

Loans - Schedule of Transactions Related to Troubled Debt Restructurings (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2016USD ($)
Troubled debt restructurings
Beginning balance	$ 42,033
New restructurings	10,316
Net paydowns	(15,591)
Charge-offs	(6,454)
Ending balance	30,304
Performing
Troubled debt restructurings
Beginning balance	28,196
New restructurings	7,521
Change in accrual status	(912)
Net paydowns	(9,514)
Ending balance	25,291
Nonperforming
Troubled debt restructurings
Beginning balance	13,837
New restructurings	2,795
Change in accrual status	912
Net paydowns	(6,077)
Charge-offs	(6,454)
Ending balance	$ 5,013

Loans - Schedule of Troubled De

Loans - Schedule of Troubled Debt Restructurings (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016USD ($)contract	Sep. 30, 2015USD ($)contract	Sep. 30, 2016USD ($)contract	Sep. 30, 2015USD ($)contract
Troubled debt restructurings
Number of contracts | contract			14	21
Pre-modification outstanding recorded investment			$ 8,692	$ 11,652
Post-modification outstanding recorded investment			7,691	7,853
Charge-offs	$ 0	$ 0	$ 0	$ 0
Commercial
Troubled debt restructurings
Number of contracts | contract	6	5	13	19
Pre-modification outstanding recorded investment	$ 4,622	$ 3,324	$ 8,615	$ 10,504
Post-modification outstanding recorded investment	$ 4,201	$ 2,194	$ 7,618	$ 6,717
Consumer
Troubled debt restructurings
Number of contracts | contract			1	1
Pre-modification outstanding recorded investment			$ 77	$ 148
Post-modification outstanding recorded investment			$ 73	$ 136
Manufacturing | Commercial
Troubled debt restructurings
Number of contracts | contract		1	1	4
Pre-modification outstanding recorded investment		$ 191	$ 50	$ 2,117
Post-modification outstanding recorded investment		$ 191	$ 23	$ 1,512
Finance and insurance | Commercial
Troubled debt restructurings
Number of contracts | contract				1
Pre-modification outstanding recorded investment				$ 75
Post-modification outstanding recorded investment				$ 48
Health care
Troubled debt restructurings
Number of contracts | contract			1
Pre-modification outstanding recorded investment			$ 100
Post-modification outstanding recorded investment			$ 100
Construction | Commercial
Troubled debt restructurings
Number of contracts | contract	2	1	3	2
Pre-modification outstanding recorded investment	$ 1,500	$ 813	$ 1,825	$ 1,638
Post-modification outstanding recorded investment	$ 1,444	$ 773	$ 1,769	$ 973
Commercial - Other | Commercial
Troubled debt restructurings
Number of contracts | contract	4	3	8	12
Pre-modification outstanding recorded investment	$ 3,122	$ 2,320	$ 6,640	$ 6,674
Post-modification outstanding recorded investment	$ 2,757	$ 1,230	$ 5,726	$ 4,184
Residential and commercial owner-occupied | Real estate - mortgage
Troubled debt restructurings
Number of contracts | contract				1
Pre-modification outstanding recorded investment				$ 1,000
Post-modification outstanding recorded investment				$ 1,000

Loans - Schedule of Troubled 52

Loans - Schedule of Troubled Debt Restructurings that Subsequently Defaulted (Details) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2016USD ($)contract	Dec. 31, 2015USD ($)
Troubled debt restructurings that subsequently defaulted
Outstanding commitments on restructured loans	$ 1,500	$ 1,700
Allowance for loan losses on troubled debt restructurings	$ 1,100
Commercial
Troubled debt restructurings that subsequently defaulted
Number of contracts | contract	3
Recorded investment	$ 1,586
Commercial - Other | Commercial
Troubled debt restructurings that subsequently defaulted
Number of contracts | contract	3
Recorded investment	$ 1,586

Loans - Schedule of Nonaccrual

Loans - Schedule of Nonaccrual Loans (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Nonaccrual loans
Total nonaccrual loans	$ 5,046	$ 15,717
Commercial
Nonaccrual loans
Total nonaccrual loans	4,502	15,109
Construction and land
Nonaccrual loans
Total nonaccrual loans		27
Consumer
Nonaccrual loans
Total nonaccrual loans	103	82
Manufacturing | Commercial
Nonaccrual loans
Total nonaccrual loans	1,000	1,045
Finance and insurance | Commercial
Nonaccrual loans
Total nonaccrual loans	27	36
Real estate services | Commercial
Nonaccrual loans
Total nonaccrual loans		91
Construction | Commercial
Nonaccrual loans
Total nonaccrual loans	282	451
Commercial - Other | Commercial
Nonaccrual loans
Total nonaccrual loans	3,193	13,486
Residential and commercial owner-occupied | Real estate - mortgage
Nonaccrual loans
Total nonaccrual loans	$ 441	$ 499

Loans - Schedule of Aging of Co

Loans - Schedule of Aging of Company's Loan Portfolio (Details) - USD ($)	Sep. 30, 2016	Dec. 31, 2015
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	$ 12,153,000	$ 4,080,000
Current	2,815,358,000	2,695,429,000
Total loans, excluding fees and costs	2,827,511,000	2,699,509,000
Unearned net loan fees	(406,000)	(304,000)
Total loans	2,827,105,000	2,699,205,000
Recorded investment in loans 90 days or more past due and accruing	0	505,000
30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	8,673,000	859,000
60 - 89 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	2,483,000	591,000
90+ Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	997,000	2,630,000
Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	10,873,000	3,013,000
Current	1,184,304,000	1,171,557,000
Total loans, excluding fees and costs	1,195,177,000	1,174,570,000
Commercial | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	7,516,000	703,000
Commercial | 60 - 89 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	2,360,000	185,000
Commercial | 90+ Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	997,000	2,125,000
Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	1,139,000	317,000
Current	1,098,331,000	1,016,755,000
Total loans, excluding fees and costs	1,099,470,000	1,017,072,000
Real estate - mortgage | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	1,016,000
Real estate - mortgage | 60 - 89 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	123,000	317,000
Construction and land
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due		156,000
Current	171,686,000	201,855,000
Total loans, excluding fees and costs	171,686,000	202,011,000
Construction and land | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due		156,000
Consumer
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	141,000	594,000
Current	263,672,000	252,646,000
Total loans, excluding fees and costs	263,813,000	253,240,000
Recorded investment in loans 90 days or more past due and accruing		505,000
Consumer | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	141,000
Consumer | 60 - 89 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due		89,000
Consumer | 90+ Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due		505,000
Other
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	97,365,000	52,616,000
Total loans, excluding fees and costs	97,365,000	52,616,000
Manufacturing | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	997,000	24,000
Current	115,738,000	135,026,000
Total loans, excluding fees and costs	116,735,000	135,050,000
Manufacturing | Commercial | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due		24,000
Manufacturing | Commercial | 90+ Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	997,000
Finance and insurance | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	681,000
Current	59,410,000	64,279,000
Total loans, excluding fees and costs	60,091,000	64,279,000
Finance and insurance | Commercial | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	655,000
Finance and insurance | Commercial | 60 - 89 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	26,000
Health care | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	17,000	323,000
Current	135,598,000	126,188,000
Total loans, excluding fees and costs	135,615,000	126,511,000
Health care | Commercial | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due		323,000
Health care | Commercial | 60 - 89 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	17,000
Real estate services | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	3,664,000	183,000
Current	120,489,000	118,680,000
Total loans, excluding fees and costs	124,153,000	118,863,000
Real estate services | Commercial | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	3,664,000	183,000
Construction | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	68,911,000	57,906,000
Total loans, excluding fees and costs	68,911,000	57,906,000
Wholesale and retail trade | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current	247,115,000	221,112,000
Total loans, excluding fees and costs	247,115,000	221,112,000
Commercial - Other | Commercial
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	5,514,000	2,483,000
Current	437,043,000	448,366,000
Total loans, excluding fees and costs	442,557,000	450,849,000
Commercial - Other | Commercial | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	3,197,000	173,000
Commercial - Other | Commercial | 60 - 89 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	2,317,000	185,000
Commercial - Other | Commercial | 90+ Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due		2,125,000
Residential and commercial owner-occupied | Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	123,000	317,000
Current	473,583,000	436,538,000
Total loans, excluding fees and costs	473,706,000	436,855,000
Residential and commercial owner-occupied | Real estate - mortgage | 60 - 89 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	123,000	317,000
Residential and commercial investor | Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	1,016,000
Current	624,748,000	578,892,000
Total loans, excluding fees and costs	625,764,000	578,892,000
Residential and commercial investor | Real estate - mortgage | 30 - 59 Days past due
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total past due	$ 1,016,000
Real estate - mortgage - Other | Real estate - mortgage
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current		1,325,000
Total loans, excluding fees and costs		$ 1,325,000

Accumulated Other Comprehensi55

Accumulated Other Comprehensive Income - Reclassifications (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Reclassifications from AOCI
Net gain (loss) on securities, other assets and OREO	$ 98	$ 59	$ 88	$ 123
Interest on taxable/nontaxable securities	32,308	30,177	95,003	90,185
Interest and fees on loans	29,124	26,758	85,020	79,959
Interest expense on subordinated debentures	(1,851)	(1,848)	(5,530)	(3,888)
(Income) loss before taxes	(13,812)	(9,291)	(35,256)	(30,632)
Provision for income taxes	(3,543)	(2,337)	(9,090)	(8,892)
Total reclassifications out of AOCI	10,269	6,921	26,166	21,349
Reclassification out of AOCI
Reclassifications from AOCI
Total reclassifications out of AOCI	176	208	402	415
Reclassification out of AOCI | Cash flow hedges | Unrealized (gain) loss on derivatives
Reclassifications from AOCI
Interest and fees on loans	151	233	463	698
Interest expense on subordinated debentures	(426)	(495)	(1,296)	(1,522)
(Income) loss before taxes	(275)	(262)	(833)	(824)
Provision for income taxes	105	99	317	313
Total reclassifications out of AOCI	(170)	(163)	(516)	(511)
Reclassification out of AOCI | Available for sale securities | Unrealized (gain) loss on securities
Reclassifications from AOCI
Net gain (loss) on securities, other assets and OREO	98	(15)	95	83
Provision for income taxes	(37)	4	(36)	(33)
Total reclassifications out of AOCI	61	(11)	59	50
Reclassification out of AOCI | Held to maturity securities | Unrealized (gain) loss on securities
Reclassifications from AOCI
Interest on taxable/nontaxable securities	459	616	1,385	1,413
Provision for income taxes	(174)	(234)	(526)	(537)
Total reclassifications out of AOCI	$ 285	$ 382	$ 859	$ 876

Accumulated Other Comprehensi56

Accumulated Other Comprehensive Income - AOCI rollforward (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Changes in AOCI
BALANCE - beginning of period			$ 273,536
Other comprehensive income (loss), net of tax	$ 570	$ (1,425)	(1,035)	$ (769)
BALANCE - end of period	295,837		295,837
Accumulated Comprehensive Income (Loss)
Changes in AOCI
BALANCE - beginning of period			3,283
Other comprehensive income (loss) items			(633)
Reclassifications			(402)
Other comprehensive income (loss), net of tax			(1,035)
BALANCE - end of period	2,248		2,248
Unrealized (gain) loss on securities | Available for sale securities
Changes in AOCI
BALANCE - beginning of period			1,724
Other comprehensive income (loss) items			742
Reclassifications			(59)
Other comprehensive income (loss), net of tax			683
BALANCE - end of period	2,407		2,407
Unrealized (gain) loss on securities | Held to maturity securities
Changes in AOCI
BALANCE - beginning of period			4,289
Reclassifications			(859)
Other comprehensive income (loss), net of tax			(859)
BALANCE - end of period	3,430		3,430
Unrealized (gain) loss on derivatives
Changes in AOCI
BALANCE - beginning of period			(2,730)
Other comprehensive income (loss) items			(1,375)
Reclassifications			516
Other comprehensive income (loss), net of tax			(859)
BALANCE - end of period	$ (3,589)		$ (3,589)

Derivatives - Narrative (Detail

Derivatives - Narrative (Details) $ in Millions	1 Months Ended	3 Months Ended			9 Months Ended
	Oct. 31, 2016USD ($)contract	Sep. 30, 2016USD ($)derivative	Mar. 31, 2016USD ($)derivative	Sep. 30, 2015USD ($)	Sep. 30, 2016USD ($)derivative	Sep. 30, 2015USD ($)
Cash flow, Fair value, and non-designated hedges
Fair value of derivatives in a net liability position		$ 16.9			$ 16.9
Collateral already posted		15.7			15.7
Cash flow hedges
Cash flow, Fair value, and non-designated hedges
Net amount recognized for hedge ineffectiveness		0		$ 0	0	$ 0
Interest Income
Cash flow, Fair value, and non-designated hedges
Estimated gains (losses) to be reclassified as earnings in next 12 months		0.6			0.6
Interest Expense
Cash flow, Fair value, and non-designated hedges
Estimated gains (losses) to be reclassified as earnings in next 12 months		1.5			1.5
Other Income | Fair value hedges
Cash flow, Fair value, and non-designated hedges
Net amount recognized for hedge ineffectiveness					$ 0.3
Interest rate swap | Minimum | Cash flow hedges | Variable rate borrowings
Cash flow, Fair value, and non-designated hedges
Derivative remaining maturities					4 years
Interest rate swap | Maximum | Cash flow hedges | Variable rate borrowings
Cash flow, Fair value, and non-designated hedges
Derivative remaining maturities					8 years
Derivatives designated as hedging instruments | Interest rate swap | Cash flow hedges | Variable rate loan assets
Cash flow, Fair value, and non-designated hedges
Number of interest rate swaps terminated | derivative			5
Notional amount of derivative instrument	$ 100		$ 75
Unrealized gain on derivatives			$ 1.3
Number of derivative contracts entered | contract	2
Weighted average term	6 years
Fixed rate	1.23%
Derivatives designated as hedging instruments | Interest rate swap | Fair value hedges
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument		$ 63.4			$ 63.4
Number of interest-rate swaps held | derivative		11			11
Derivatives not designated as hedging instruments
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument		$ 210.6			$ 210.6
Derivatives not designated as hedging instruments | Interest rate swap
Cash flow, Fair value, and non-designated hedges
Number of interest-rate swaps held | derivative		90			90
Derivatives not designated as hedging instruments | Foreign exchange forward contracts
Cash flow, Fair value, and non-designated hedges
Notional amount of derivative instrument		$ 5.5			$ 5.5
Net gains recognized on derivative		$ 0.1		$ 0.3	$ 0.1	$ 0.3

Derivatives - Schedule of Deriv

Derivatives - Schedule of Derivatives Instruments in Statements of Financial Position (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Derivatives designated as hedging instruments | Interest rate swap | Other assets | Cash flow hedges
Derivatives at fair value
Asset derivatives, designated as hedging at Fair value		$ 578
Derivatives designated as hedging instruments | Interest rate swap | Other assets | Fair value hedges
Derivatives at fair value
Asset derivatives, designated as hedging at Fair value		117
Derivatives designated as hedging instruments | Interest rate swap | Accrued interest and other liabilities | Cash flow hedges
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	$ 6,728	4,981
Derivatives designated as hedging instruments | Interest rate swap | Accrued interest and other liabilities | Fair value hedges
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	4,707	1,574
Derivatives not designated as hedging instruments | Interest rate swap | Other assets
Derivatives at fair value
Asset derivatives, designated as hedging at Fair value	4,490	3,092
Derivatives not designated as hedging instruments | Interest rate swap | Accrued interest and other liabilities
Derivatives at fair value
Liability derivatives, designated as hedging at Fair value	4,828	3,275
Derivatives not designated as hedging instruments | Foreign exchange forward contracts | Other assets
Derivatives at fair value
Asset derivatives, not designated as hedging at Fair value	8	109
Derivatives not designated as hedging instruments | Foreign exchange forward contracts | Accrued interest and other liabilities
Derivatives at fair value
Liability derivatives, not designated as hedging at Fair value	$ 45	$ 59

Derivatives - Schedule of Fair

Derivatives - Schedule of Fair Value of Derivative Financial Instruments and Classification on Condensed Consolidated Balance Sheets (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Derivative assets, net
Gross amounts of recognized assets	$ 4,498	$ 3,896
Net amounts included in other assets in the Condensed Consolidated Balance Sheets	4,498	3,896
Gross amounts not offset - Financial instruments	(8)	(404)
Gross amounts not offset - Net Amount	4,490	3,492
Securities sold under agreements to repurchase
Gross amounts of recognized liabilities	(52,114)	(47,459)
Net amounts included in accrued interest and other liabilities in the Consolidated Balance Sheets	(52,114)	(47,459)
Gross amounts not offset - Collateral	52,114	47,459
Total offsetting derivative liabilities and securities sold under agreements to repurchase
Gross amounts of recognized liabilities	(68,422)	(57,348)
Net amounts included in accrued interest and other liabilities in the Consolidated Balance Sheets	(68,422)	(57,348)
Gross amounts not offset - Financial instruments	8	404
Gross amounts not offset - Collateral	67,849	56,633
Gross amounts not offset - Net Amount	(565)	(311)
Derivatives designated as hedging instruments
Derivative assets, net
Gross amounts of recognized assets		695
Net amounts included in other assets in the Condensed Consolidated Balance Sheets		695
Gross amounts not offset - Financial instruments		(316)
Gross amounts not offset - Net Amount		379
Derivatives designated as hedges or not designated as hedges
Gross amounts of recognized liabilities	(11,435)	(6,555)
Net amounts included in accrued interest and other liabilities' in the condensed consolidated balance sheets	(11,435)	(6,555)
Gross amounts not offset - Financial instruments		316
Gross amounts not offset - Collateral	11,435	6,239
Derivatives not designated as hedging instruments
Derivative assets, net
Gross amounts of recognized assets	4,498	3,201
Net amounts included in other assets in the Condensed Consolidated Balance Sheets	4,498	3,201
Gross amounts not offset - Financial instruments	(8)	(88)
Gross amounts not offset - Net Amount	4,490	3,113
Derivatives designated as hedges or not designated as hedges
Gross amounts of recognized liabilities	(4,873)	(3,334)
Net amounts included in accrued interest and other liabilities' in the condensed consolidated balance sheets	(4,873)	(3,334)
Gross amounts not offset - Financial instruments	8	88
Gross amounts not offset - Collateral	4,300	2,935
Gross amounts not offset - Net Amount	$ (565)	$ (311)

Derivatives - Schedule of Notio

Derivatives - Schedule of Notional Amounts of Outstanding Derivative Positions (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2016USD ($)
CoBiz Statutory Trust I
Derivatives, statutory trusts
Notional amount of derivative instrument	$ 20,000
Fixed rate	4.99%
Termination date	Mar. 17, 2022
CoBiz Capital Trust II
Derivatives, statutory trusts
Notional amount of derivative instrument	$ 30,000
Fixed rate	5.99%
Termination date	Apr. 23, 2020
CoBiz Capital Trust III
Derivatives, statutory trusts
Notional amount of derivative instrument	$ 20,000
Fixed rate	5.02%
Termination date	Mar. 30, 2024

Borrowed Funds - Schedule of Se

Borrowed Funds - Schedule of Securities Sold Under Agreements to Repurchase (Details) - USD ($)	3 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Borrowed Funds
Securities sold under agreements to repurchase	$ 52,114,000	$ 47,459,000
Fair value of securities sold under agreements to repurchase	53,156,000	49,882,000
Maximum borrowing capacity	$ 20,000,000
Basis spread on variable rate	2.25%
Commitment fee percentage on the unused portion of the LOC	0.35%
Amount outstanding	$ 0	$ 0

Employee Benefit and Stock Co62

Employee Benefit and Stock Compensation Plans - Narrative (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2016	Sep. 30, 2016
Employee Benefit and Stock Compensation Plans
Share-based compensation expense	$ 0.7	$ 2.5

Employee Benefit and Stock Co63

Employee Benefit and Stock Compensation Plans - Summary of Changes in Stock Option Awards (Details)	9 Months Ended
	Sep. 30, 2016$ / sharesshares
Employee Benefit and Stock Compensation Plans
Shares, Outstanding - beginning of year | shares	461,050
Shares, Granted | shares	41,403
Shares, Exercised | shares	(133,317)
Shares, Forfeited | shares	(10,016)
Shares, Outstanding - end of year | shares	359,120
Shares, Exercisable - end of year | shares	253,139
Weighted average exercise price, Outstanding - beginning of year	$ 8.87
Weighted average exercise price, Granted	11.53
Weighted average exercise price, Exercised	7.66
Weighted average exercise price, Forfeited	7.11
Weighted average exercise price, Outstanding - end of year	9.68
Weighted average exercise price, Exercisable - end of year	8.84
Weighted average grant date fair value of options granted	$ 2.29

Employee Benefit and Stock Co64

Employee Benefit and Stock Compensation Plans - Summary of Changes in Stock Awards (Details) $ / shares in Units, $ in Millions	9 Months Ended
	Sep. 30, 2016USD ($)$ / sharesshares
Employee Benefit and Stock Compensation Plans
Shares, Unvested - beginning of year | shares	500,034
Shares, Granted | shares	282,383
Shares, Vested | shares	(289,861)
Shares, Forfeited | shares	(23,626)
Shares, Unvested - end of year | shares	468,930
Weighted average grant date fair value, Unvested - beginning of year | $ / shares	$ 10.85
Weighted average grant date fair value, Granted | $ / shares	11.53
Weighted average grant date fair value, Vested | $ / shares	10.44
Weighted average grant date fair value, Forfeited | $ / shares	11.45
Weighted average grant date fair value, Unvested - end of year | $ / shares	$ 11.49
Total unrecognized compensation expense related to unvested share-based compensation arrangements granted under equity incentive plans | $	$ 4.1
Unrecognized compensation expense related to unvested share-based compensation arrangements, expected weighted average recognition period, years	1 year 10 months 24 days

Leases (Details)

Leases (Details) $ in Thousands	1 Months Ended
	Jan. 31, 2016ft²	Sep. 30, 2016USD ($)
Leases
Lease term	12 years
Annual Rent escalation (as a percent)	2.00%
Future lease payments
2,016		$ 1,152
2,017		4,837
2,018		4,625
2,019		4,318
2,020		3,231
Thereafter		16,172
Total		$ 34,335
Office Space
Leases
Area of space leased (in square feet) | ft²	44,010
Ground level retail space
Leases
Area of space leased (in square feet) | ft²	4,000

Segments - Summary of Results O

Segments - Summary of Results Of Operations by Operating Segment (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Segments
Total interest income	$ 32,308	$ 30,177	$ 95,003	$ 90,185
Total interest expense	2,907	2,810	8,840	6,745
Provision for loan losses	(1,168)	762	(2,450)	1,030
Noninterest income	9,286	7,424	24,786	22,682
Noninterest expense	26,043	24,738	78,143	74,460
Provision (benefit) for income taxes	3,543	2,337	9,090	8,892
Net income from continuing operations	10,269	6,954	26,166	21,740
Net income (loss) from discontinued operations				(71)
Net income (loss)	10,269	6,954	26,166	21,669
Commercial Banking
Segments
Total interest income	32,216	30,084	94,727	88,909
Total interest expense	1,078	986	3,369	2,926
Provision for loan losses	(1,158)	774	(2,300)	1,160
Noninterest income	3,622	2,765	9,318	8,208
Noninterest expense	9,731	8,445	27,715	26,988
Management fees and allocations	7,757	6,627	23,831	19,429
Provision (benefit) for income taxes	7,535	7,451	21,888	22,366
Net income from continuing operations				24,248
Net income (loss)	10,895	8,566	29,542	24,248
Fee-Based Lines
Segments
Total interest income		1	1	2
Total interest expense	11	12	25	33
Noninterest income	4,536	4,501	13,578	13,554
Noninterest expense	4,055	4,080	12,807	11,994
Management fees and allocations	464	280	1,255	892
Provision (benefit) for income taxes	165	109	277	565
Net income from continuing operations				72
Net income (loss) from discontinued operations				(71)
Net income (loss)	(159)	21	(785)	1
Corporate Support and Other
Segments
Total interest income	92	92	275	1,274
Total interest expense	1,818	1,812	5,446	3,786
Provision for loan losses	(10)	(12)	(150)	(130)
Noninterest income	1,128	158	1,890	920
Noninterest expense	12,257	12,213	37,621	35,478
Management fees and allocations	(8,221)	(6,907)	(25,086)	(20,321)
Provision (benefit) for income taxes	(4,157)	(5,223)	(13,075)	(14,039)
Net income from continuing operations				(2,580)
Net income (loss)	$ (467)	$ (1,633)	$ (2,591)	$ (2,580)

Fair Value Measurements - Finan

Fair Value Measurements - Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Assets and liabilities measured at fair value
Investment securities available for sale	$ 140,283	$ 153,685
Total derivative assets	4,498	3,896
Trust preferred securities
Assets and liabilities measured at fair value
Investment securities available for sale	37,529	46,083
Corporate debt securities
Assets and liabilities measured at fair value
Investment securities available for sale	99,378	103,736
Derivatives designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets		695
Total derivative liabilities	11,435	6,555
Derivatives not designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets	4,498	3,201
Total derivative liabilities	4,873	3,334
Recurring
Assets and liabilities measured at fair value
Investment securities available for sale	140,283	153,685
Total derivative assets	4,498	3,896
Total derivative liabilities	16,308	9,889
Recurring | Quoted prices in active markets for identical assets (Level 1)
Assets and liabilities measured at fair value
Investment securities available for sale	4,326	13,090
Recurring | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	126,682	134,785
Total derivative assets	4,498	3,896
Total derivative liabilities	16,308	9,889
Recurring | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Investment securities available for sale	9,275	5,810
Recurring | Trust preferred securities
Assets and liabilities measured at fair value
Investment securities available for sale	37,529	46,083
Recurring | Trust preferred securities | Quoted prices in active markets for identical assets (Level 1)
Assets and liabilities measured at fair value
Investment securities available for sale	4,326	13,090
Recurring | Trust preferred securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	23,928	27,183
Recurring | Trust preferred securities | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Investment securities available for sale	9,275	5,810
Recurring | Corporate debt securities
Assets and liabilities measured at fair value
Investment securities available for sale	99,378	103,736
Recurring | Corporate debt securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	99,378	103,736
Recurring | Municipal securities
Assets and liabilities measured at fair value
Investment securities available for sale	3,376	3,866
Recurring | Municipal securities | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Investment securities available for sale	3,376	3,866
Recurring | Foreign exchange forward contracts
Assets and liabilities measured at fair value
Total derivative liabilities		59
Recurring | Foreign exchange forward contracts | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Total derivative liabilities		59
Recurring | Derivatives designated as hedging instruments | Cash flow hedges
Assets and liabilities measured at fair value
Total derivative assets		578
Total derivative liabilities	6,728	4,981
Recurring | Derivatives designated as hedging instruments | Fair value hedges
Assets and liabilities measured at fair value
Total derivative assets		117
Total derivative liabilities	4,707	1,574
Recurring | Derivatives designated as hedging instruments | Significant other observable inputs (Level 2) | Cash flow hedges
Assets and liabilities measured at fair value
Total derivative assets		578
Total derivative liabilities	6,728	4,981
Recurring | Derivatives designated as hedging instruments | Significant other observable inputs (Level 2) | Fair value hedges
Assets and liabilities measured at fair value
Total derivative assets		117
Total derivative liabilities	4,707	1,574
Recurring | Derivatives not designated as hedging instruments
Assets and liabilities measured at fair value
Total derivative assets	4,490	3,092
Total derivative liabilities	4,828	3,275
Recurring | Derivatives not designated as hedging instruments | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Total derivative assets	4,490	3,092
Total derivative liabilities	4,828	3,275
Recurring | Derivatives not designated as hedging instruments | Foreign exchange forward contracts
Assets and liabilities measured at fair value
Total derivative assets	8	109
Total derivative liabilities	45
Recurring | Derivatives not designated as hedging instruments | Foreign exchange forward contracts | Significant other observable inputs (Level 2)
Assets and liabilities measured at fair value
Total derivative assets	8	$ 109
Total derivative liabilities	$ 45

Fair Value Measurements - Recon

Fair Value Measurements - Reconcoliation of the Beginning and Ending Balance of Financial Assets Measured At Fair Value On Recurring Basis Using Level 3 Inputs (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Reconciliation of Level 3 inputs
Beginning balance	$ 8,955	$ 5,867	$ 5,810	$ 6,754
Transfers and purchases			3,276
Net accretion	29	15	60	54
Sales/calls/maturities				(995)
Unrealized gain (loss) included in comprehensive income	291	124	129	193
Ending balance	$ 9,275	$ 6,006	$ 9,275	$ 6,006

Fair Value Measurements - Sched

Fair Value Measurements - Schedule of Financial Assets Measured at Fair Value on Nonrecurring Basis (OREO and Impaired Loans) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015	Dec. 31, 2015
Assets and liabilities measured at fair value
OREO recorded at fair value	$ 5,351		$ 5,351		$ 5,351
Provision for loan losses			(2,450)	$ 1,030
OREO
Assets and liabilities measured at fair value
OREO recorded at fair value	5,351		5,351		5,351
Year to date gain (loss)		$ 78		45
Impaired Loans
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	2,536		2,536		6,296
Provision for loan losses	975	$ 62	3,149	$ 1,036
Nonrecurring | OREO
Assets and liabilities measured at fair value
OREO recorded at fair value	5,351		5,351		5,351
Nonrecurring | OREO | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
OREO recorded at fair value	5,351		5,351		5,351
Nonrecurring | Impaired Loans
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	2,536		2,536		6,296
Nonrecurring | Impaired Loans | Significant unobservable inputs (Level 3)
Assets and liabilities measured at fair value
Impaired loans, net of specific reserve	$ 2,536		$ 2,536		$ 6,296

Fair Value Measurements - Sch70

Fair Value Measurements - Schedule of Reconciliation of Fair Value Measurement of Other Real Estate Owned (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015
Fair Value Measurements
OREO recorded at fair value	$ 5,351	$ 5,351
Estimated selling costs	(272)	(272)
OREO	$ 5,079	$ 5,079

Fair Value Measurements - Summa

Fair Value Measurements - Summary of Other Real Estate Owned Transactions (Details) $ in Thousands	9 Months Ended
	Sep. 30, 2016USD ($)
Fair Value Measurements
Beginning balance	$ 5,079
OREO sales	0
Valuation adjustments	0
Ending balance	$ 5,079

Fair Value Measurements - Sch72

Fair Value Measurements - Schedule of Valuation Process Used to Determine Fair Value Measurement within Level 3 (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2016	Dec. 31, 2015
Fair value valuation processes
Investment securities available for sale	$ 140,283	$ 153,685
OREO recorded at fair value	5,351	5,351
Impaired Loans
Fair value valuation processes
Impaired loans	2,536	6,296
OREO
Fair value valuation processes
OREO recorded at fair value	5,351	5,351
Market approach | Trust preferred securities
Fair value valuation processes
Investment securities available for sale	$ 9,275	$ 5,810
Valuation Technique	Market approach	Market approach
Unobservable Input	Discount to carrying value using broker quotes or observable prices on similar securities	Discount to carrying value using broker quotes or observable prices on similar securities
Market approach | Weighted Average | Trust preferred securities
Fair value valuation processes
Discount rate	14.00%	15.00%
Market approach | Minimum | Trust preferred securities
Fair value valuation processes
Discount rate	1.00%	1.00%
Market approach | Maximum | Trust preferred securities
Fair value valuation processes
Discount rate	20.00%	18.00%
Commercial | Market approach | Minimum | Impaired Loans
Fair value valuation processes
Discount rate		81.00%
Commercial | Market approach | Maximum | Impaired Loans
Fair value valuation processes
Discount rate		0.00%
Commercial | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 1,323	$ 5,006
Valuation Technique	Sales comparison (1)	Sales comparison (1)
Unobservable Input	Management discount for asset type	Management discount for asset type
Commercial | Sales comparison | Weighted Average | Impaired Loans
Fair value valuation processes
Discount rate	33.00%	47.00%
Commercial | Property appraisals | OREO
Fair value valuation processes
OREO recorded at fair value	$ 190	$ 190
Valuation Technique	Property appraisals (2)	Property appraisals (2)
Unobservable Input	Management discount for property type and recent market volatility	Management discount for property type and recent market volatility
Commercial | Property appraisals | Weighted Average | OREO
Fair value valuation processes
Discount rate	0.00%	0.00%
Commercial | Property appraisals | Minimum | Impaired Loans
Fair value valuation processes
Discount rate	0.00%
Commercial | Property appraisals | Minimum | OREO
Fair value valuation processes
Discount rate		0.00%
Commercial | Property appraisals | Maximum | Impaired Loans
Fair value valuation processes
Discount rate	76.00%
Commercial | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 748	$ 667
Valuation Technique	Sales comparison (2)	Sales comparison (2)
Unobservable Input	Sales comparison adjustments	Sales comparison adjustments
Commercial | Sales comparison | Weighted Average | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	(38.00%)	(32.00%)
Real estate - mortgage | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 441	$ 487
Valuation Technique	Sales comparison (2)	Sales comparison (2)
Unobservable Input	Sales comparison adjustments	Sales comparison adjustments
Real estate - mortgage | Sales comparison | Weighted Average | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	16.00%	12.00%
Real estate - mortgage | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	9.00%	(15.00%)
Real estate - mortgage | Sales comparison | Maximum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	18.00%	17.00%
Construction and land | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans		$ 27
Valuation Technique		Sales comparison (2)
Unobservable Input		Sales comparison adjustments
Construction and land | Sales comparison | Weighted Average | Impaired Loans
Fair value valuation processes
Sales comparison adjustments		(24.00%)
Construction and land | Property appraisals | OREO
Fair value valuation processes
OREO recorded at fair value	$ 5,161	$ 5,161
Valuation Technique	Property appraisals (2)	Property appraisals (2)
Unobservable Input	Management discount for property type and recent market volatility	Management discount for property type and recent market volatility
Construction and land | Property appraisals | Weighted Average | OREO
Fair value valuation processes
Discount rate	17.00%	17.00%
Consumer | Sales comparison | Impaired Loans
Fair value valuation processes
Impaired loans	$ 24	$ 109
Valuation Technique	Sales comparison (2)	Sales comparison (2)
Unobservable Input	Sales comparison adjustments	Sales comparison adjustments
Consumer | Sales comparison | Weighted Average | Impaired Loans
Fair value valuation processes
Sales comparison adjustments	10.00%	11.00%
Consumer | Sales comparison | Minimum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments		(2.00%)
Consumer | Sales comparison | Maximum | Impaired Loans
Fair value valuation processes
Sales comparison adjustments		14.00%

Fair Value Measurements - Sch73

Fair Value Measurements - Schedule of Estimated Fair Value of Other Financial Instruments (Details) - USD ($) $ in Thousands	Sep. 30, 2016	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014
Fair value of financial instruments
Cash and cash equivalents	$ 86,148	$ 67,312	$ 93,949	$ 91,565
Investment securities available for sale	140,283	153,685
Investment securities held to maturity	307,639	346,666
Other investments	7,160	12,461
Loans - net	2,793,576	2,658,519
Accrued interest receivable	10,994	10,362
Derivatives assets	4,498	3,896
Deposits.	2,937,193	2,741,712
Securities sold under agreements to repurchase	52,114	47,459
Short-term borrowings	2,199	132,000
Subordinated notes payable	59,090	59,031
Junior subordinated debentures	72,166	72,166
Carrying Value
Fair value of financial instruments
Cash and cash equivalents	86,148	67,312
Investment securities available for sale	140,283	153,685
Investment securities held to maturity	307,639	346,666
Other investments	7,160	12,461
Loans - net	2,793,576	2,658,519
Accrued interest receivable	10,994	10,362
Derivatives assets	4,498	3,896
Deposits.	2,937,193	2,741,712
Securities sold under agreements to repurchase	52,114	47,459
Short-term borrowings	2,199	132,000
Accrued interest payable	1,834	1,134
Subordinated notes payable	59,090	59,031
Junior subordinated debentures	72,166	72,166
Derivatives liabilities	16,308	9,889
Total Fair Value
Fair value of financial instruments
Cash and cash equivalents	86,148	67,312
Investment securities available for sale	140,283	153,685
Investment securities held to maturity	308,998	345,576
Other investments	7,160	12,461
Loans - net	2,786,164	2,647,448
Accrued interest receivable	10,994	10,362
Derivatives assets	4,498	3,896
Deposits.	2,936,561	2,741,366
Securities sold under agreements to repurchase	50,452	45,474
Short-term borrowings	2,199	132,000
Accrued interest payable	1,834	1,134
Subordinated notes payable	62,113	59,080
Junior subordinated debentures	72,166	72,166
Derivatives liabilities	$ 16,308	$ 9,889

Regulatory Matters - Schedule o

Regulatory Matters - Schedule of Regulatory Capital Amounts and Ratios of Company and Bank (Details)	9 Months Ended
	Sep. 30, 2016
Regulatory matters
Minimum Capital Conservation Buffer (as percent)	0.625%
Annual increase in minimum Capital Conservation Buffer (as percent)	0.625%
Increased Capital Conservation Buffer (as percent)	2.50%
Common Tier 1, Risk-based, Capital ratios (as a percent)	9.70%
Common Tier 1, Risk-based, Well-capitalized requirement (as a percent)	6.50%
Common Tier 1, Risk-based, Minimum capital requirement (as a percent)	7.00%
Tier I, Risk-based, Capital ratios (as a percent)	11.50%
Tier I, Risk-based, Well-capitalized requirement (as a percent)	8.00%
Tier I, Risk-based, Minimum capital requirement (as a percent)	8.50%
Total capital, Risk-based, Capital ratios (as a percent)	14.50%
Total capital, Risk-based, Well-capitalized requirement (as a percent)	10.00%
Total capital, Risk-based, Minimum capital requirement (as a percent)	10.50%
Tier I, Leverage, Capital ratios (as a percent)	10.10%
Tier I, Leverage, Well-capitalized requirement (as a percent)	5.00%
Tier I, Leverage, Minimum capital requirement (as a percent)	4.00%
Bank
Regulatory matters
Common Tier 1, Risk-based, Capital ratios (as a percent)	11.90%
Tier I, Risk-based, Capital ratios (as a percent)	11.90%
Total capital, Risk-based, Capital ratios (as a percent)	12.90%
Tier I, Leverage, Capital ratios (as a percent)	10.40%

Supplemental Financial Data (De

Supplemental Financial Data (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2016	Sep. 30, 2015	Sep. 30, 2016	Sep. 30, 2015
Other noninterest income
Loan Fees	$ 795	$ 466	$ 1,737	$ 1,179
Other customer service fees	694	709	2,023	1,838
Bank-owned life insurance	345	349	1,000	980
Equity method investments	1,348	70	2,262	859
Interest rate swap		(156)	(456)	(179)
Other income	15	(5)	134	13
Other noninterest income	3,197	1,433	6,700	4,690
Other noninterest expense
Marketing and business development	559	646	2,104	2,114
Service contracts	1,331	1,342	3,855	3,349
Professional fees	824	770	2,135	1,906
Office supplies and delivery	336	428	972	1,069
Other expense	947	903	2,861	2,601
Other noninterest expense	$ 3,997	$ 4,089	$ 11,927	$ 11,039